Craig Mayer, Nick WIlliams, Vojtech Huser
Lister Hill National Center for Biomedical Communications, National Library of Medicine, NIH, Bethesda, MD

See the full regCTG repository at https://github.com/lhncbc/CRI/tree/master/regCTG

To return to the list of conditions and view other reports go to https://lhncbc.github.io/CRI/regCTG/regCTG-condition_report_links.html


Study Counts

Type Study_count
Total_Studies 588
interventional 496
Observational 84
Registry 8

Studies over Time by Start Date

```

Interventional Trials

Intervention Type

intervention_type Study_Count
Drug 188
Drug|placebo 106
Other 46
Behavioral 45
Dietary Supplement 30
Dietary Supplement|placebo 24
Biological 7
Biological|Drug|placebo 5
Behavioral|Other 4
Dietary Supplement|Drug 4
Dietary Supplement|Other 4
Biological|placebo 3
Device 3
Drug|Other 3
Drug|Other|placebo 3
Other|placebo 3
Behavioral|Procedure 2
placebo 2
Procedure 2
Behavioral|Device 1
Behavioral|Device|Other 1
Behavioral|Dietary Supplement 1
Behavioral|Dietary Supplement|placebo 1
Behavioral|Drug 1
Behavioral|Other|Procedure 1
Biological|Drug 1
Device|Drug 1
Diagnostic Test 1
Dietary Supplement|Drug|Other|placebo 1
Dietary Supplement|Drug|placebo 1
Dietary Supplement|Other|placebo 1

Count of Studies by Intervention (normalized and mapped)

Interventions over Time

Yearly studies for each intervention by start date

Studies by Country

Country Study_Count
United States 146
NA 59
Korea, Republic of 52
China 16
Canada 15
Netherlands 11
Brazil 9
United Kingdom 9
United States|Canada 9
Australia 8
France 8
Spain 8
Germany 7
Italy 7
Japan 6
Switzerland 6
Denmark 5
Sweden 5
India 4
Mexico 4
Belgium 3
Israel 3
Norway 3
Pakistan 3
Turkey 3
Cameroon 2
Chile 2
Denmark|Germany|India|Netherlands|Poland|United Kingdom 2
Denmark|Germany|Israel|Netherlands|United Kingdom 2
Finland 2
Indonesia 2
Iran, Islamic Republic of 2
Iraq 2
Lebanon 2
Poland 2
Russian Federation 2
Slovenia 2
United States|Australia|Canada 2
United States|Brazil|Canada|Singapore|South Africa|Taiwan|United Kingdom 2
United States|Puerto Rico 2
Argentina 1
Argentina|Czech Republic|Germany|Mexico|Poland|Romania|Russian Federation 1
Australia|New Zealand 1
Austria|Belgium|Finland|Greece|Hungary|Ireland|Italy|Portugal|Slovenia|Spain|Switzerland| 1
Belarus|Bulgaria|Croatia|Denmark|Indonesia|Israel|Italy|Latvia|Lithuania|Malaysia|Romania|Singapore|Thailand 1
Belgium|Denmark|Estonia|Finland|France|Germany|Lithuania|Netherlands|Norway|Portugal|Sweden 1
Belgium|Denmark|France|Germany|Italy|Portugal|Sweden 1
Brazil|Chile|Colombia|Ecuador|Guatemala|Mexico|Panama|Venezuela 1
Brazil|India|Philippines 1
Bulgaria|United States|Argentina|Brazil|Canada|Colombia|Czechia|Denmark|France|Germany|Hungary|India|Israel|Japan|Mexico|Netherlands|Poland|Puerto Rico|Romania|Slovakia|Russian Federation|South Africa|Spain|Ukraine|United Kingdom 1
Cameroon|Canada|Italy|Spain|United Kingdom| 1
Canada|United Kingdom| 1
Czech Republic|Estonia|Finland|Germany|Poland|South Africa|United Kingdom 1
Czech Republic|France|Germany|Hong Kong|Korea, Republic of|Netherlands|Russian Federation|Slovakia|South Africa|Sweden|Taiwan|Ukraine 1
Denmark|Finland|Germany|India|Israel|Italy|Netherlands|Norway|Poland|Russian Federation|Spain|Sweden|United Kingdom 1
Denmark|Finland|Germany|India|Israel|Italy|Netherlands|Norway|Poland|Russian Federation|United Kingdom|Spain|Sweden 1
Denmark|Netherlands|Spain|Sweden 1
Egypt 1
Estonia|Latvia|Russian Federation|Serbia 1
France|Romania|Tunisia 1
Germany|Switzerland 1
Greece|Hungary|Ireland|Poland|Portugal|Russian Federation|Slovakia|Switzerland| 1
Hong Kong 1
Hungary 1
Hungary|Italy|Macedonia, The Former Yugoslav Republic of|Malaysia|Poland|Russian Federation|Serbia|Ukraine 1
Italy|Finland|Norway|Russian Federation|United Kingdom 1
Italy|Poland|Portugal|United States|Australia|Belgium|Brazil|Canada|France|Greece|Romania|South Africa|Spain|Switzerland|United Kingdom 1
Malaysia 1
Netherlands|Denmark 1
Netherlands|Denmark|Spain|Sweden 1
Poland|Czech Republic|France|Hungary|India|Lithuania|Slovakia 1
Poland|Ukraine|United Kingdom 1
Puerto Rico 1
Romania 1
South Africa 1
Taiwan 1
Thailand 1
Thailand| 1
United States|Argentina|Australia|Austria|Belgium|Brazil|Bulgaria|Canada|Chile|China|Colombia|Czechia|Denmark|Estonia|Finland|France|Germany|Greece|Hong Kong|Hungary|Iceland|India|Ireland|Israel|Italy|Japan|Korea, Republic of|Latvia|Lithuania|Malaysia|Mexico|Netherlands|New Zealand|Norway|Philippines|Poland|Portugal|Romania|Russian Federation|Singapore|Slovakia|South Africa|Spain|Sweden|Switzerland|Taiwan|Turkey|Ukraine|United Kingdom 1
United States|Argentina|Brazil|Canada|China|Colombia|France|Korea, Republic of|Russian Federation|Turkey 1
United States|Argentina|Chile|Czech Republic|Estonia|Germany|Hungary|Latvia|Lithuania|Mexico|Netherlands|Peru|Poland|Russian Federation|Slovakia|South Africa|United Kingdom 1
United States|Australia|Austria|Belgium|Canada|Czechia|Denmark|France|Germany|Hong Kong|Hungary|Italy|Japan|Korea, Republic of|Netherlands|New Zealand|Norway|Poland|Russian Federation|South Africa|Spain|Sweden|Switzerland|Taiwan|United Kingdom 1
United States|Australia|Belgium|Canada|Czechia|Denmark|Estonia|Finland|France|Germany|Greece|Hong Kong|Hungary|Italy|Japan|Latvia|Lithuania|Malaysia|Netherlands|New Zealand|Norway|Poland|Portugal|Russian Federation|Slovakia|South Africa|Spain|Sweden|Turkey|United Kingdom 1
United States|Australia|Brazil|Canada|Denmark|Hong Kong|Italy|Korea, Republic of|Malaysia|Mexico|Singapore|South Africa|Sweden|Taiwan 1
United States|Australia|Brazil|Finland|Germany|Israel|Italy|Kuwait|Lebanon|Norway|Sweden|Switzerland|Turkey|United Arab Emirates|United Kingdom 1
United States|Australia|Canada|China|Czech Republic|Denmark|France|Hungary|Mexico|Netherlands|Poland|Spain|United Kingdom 1
United States|Australia|Canada|Czech Republic|Germany|Hong Kong|Italy|Korea, Republic of|Poland 1
United States|Australia|Canada|Finland|Italy|Spain|Sweden|Switzerland 1
United States|Belgium|Canada|Italy|Mexico|Poland|Spain 1
United States|Canada|Czechia|Finland|Korea, Republic of|Netherlands|Norway|Poland|Puerto Rico|Singapore|Sweden|United Kingdom 1
United States|Canada|Netherlands 1
United States|China 1
United States|Czechia|Hungary|Poland|Russian Federation|Slovakia|Ukraine 1
United States|Denmark|Germany|Netherlands|Poland|United Kingdom 1
United States|Germany 1
United States|Hungary|Canada|Colombia|France|Lithuania|Mexico|Romania|Russian Federation|Spain|Taiwan|United Kingdom 1
United States|Jordan|Taiwan 1

Sites per Study

Site_count Study_Count
1 342
2 26
3 8
4 6
5 4
6 2
7 3
9 2
10 3
11 2
12 3
13 2
14 3
15 3
16 1
17 2
18 1
20 2
21 2
22 1
25 3
26 3
27 1
28 1
30 1
31 2
33 5
34 1
35 6
39 2
41 1
42 1
44 2
46 1
47 2
49 2
50 1
51 2
53 1
54 3
59 2
62 1
64 2
65 1
66 1
67 1
69 1
70 1
73 1
78 1
82 1
92 1
102 1
103 1
106 1
110 1
114 1
119 2
121 1
124 1
126 1
129 2
168 1
186 1
192 1
198 1
223 1
241 1
249 1
363 1
417 1
888 1
1287 1

Phase

Phase Study_Count
N/A 161
Phase 3 124
Phase 4 75
Phase 1 67
Phase 2 60
Phase 1/Phase 2 4
Phase 2/Phase 3 4
Early Phase 1 1

Number of Arms

Number_of_Arms Count_of_Studies
1 43
2 241
3 69
4 35
5 14
6 21
8 4
9 2
10 3
11 1
12 1
16 1
NA 61

Enrollment Metrics by Phase

Measure Early.Phase.1 N.A Phase.1 Phase.1.Phase.2 Phase.2 Phase.2.Phase.3 Phase.3 Phase.4
Min. 10 6.000 4.00000 25.00 8.0000 23.00 12.0000 16.0000
1st Qu. 10 30.000 26.50000 36.25 45.5000 110.75 140.0000 62.0000
Median 10 60.000 40.00000 56.00 90.5000 235.00 305.0000 150.0000
Mean 10 3373.925 58.93939 54.25 133.0333 218.75 900.0407 446.4267
3rd Qu. 10 169.500 68.75000 74.00 177.7500 343.00 732.5000 298.5000
Max. 10 500000.000 279.00000 80.00 575.0000 382.00 27564.0000 10000.0000

Trial Group Type

group_type Group_Count
Experimental 670
Active Comparator 254
Placebo Comparator 184
NA 61
Other 42
No Intervention 35
Sham Comparator 2

Intervention Model

intervention_model Study_Count
Parallel Assignment 347
Crossover Assignment 79
Single Group Assignment 56
Factorial Assignment 11
Sequential Assignment 2
NA 1

Primary Purpose

primary_purpose Study_Count
Treatment 355
Prevention 51
Basic Science 35
Health Services Research 14
NA 10
Supportive Care 9
Diagnostic 8
Other 8
Screening 6

Observational Studies

Studies by Country

Country Study_Count
NA 16
United States 13
Canada 8
Korea, Republic of 7
France 5
Greece 4
Russian Federation 3
China 2
Egypt 2
Indonesia 2
Italy 2
Taiwan 2
Algeria|Cameroon|Egypt|Ghana|Jordan|Kenya|Kuwait|Lebanon|Nigeria|Saudi Arabia|Senegal|South Africa|Tunisia|United Arab Emirates 1
Brazil 1
Bulgaria 1
Czech Republic 1
Denmark 1
Finland|Sweden 1
Germany 1
Haiti 1
India 1
Japan 1
Mexico 1
Pakistan 1
Puerto Rico 1
Romania 1
Thailand 1
Turkey 1
United Kingdom 1
United States|Puerto Rico 1

Sites per Study

Site_count Study_Count
1 63
2 3
3 3
5 2
8 1
9 1
15 1
20 1
23 1
26 1
27 1
38 1
49 1
74 1
103 1
118 1
1207 1

Enrollment Metrics

Measure Observational
Min 1.00
1st Qu 115.00
Median 618.50
Mean 3092.56
3rd Qu 2272.00
Max 120000.00

Observation Model

observational_model Study_Count
Cohort 36
Case-Only 12
NA 11
Case-Control 7
Case Control 6
Other 6
Ecologic or Community 3
Case-Crossover 2
Defined Population, Natural History 1

Time Perspective

time_perspective Study_Count
Prospective 47
Cross-Sectional 18
Retrospective 13
Longitudinal, Prospective 2
Other 2
NA 2

Registries

Studies by Country

Country Study_Count
NA 3
Belgium|Finland|France|Germany|Greece|Italy|Netherlands|Portugal|Spain|Sweden|Switzerland|United Kingdom 1
Canada 1
Mexico 1
Taiwan 1
Tunisia 1

Sites per Study

Site_count Study_Count
1 7
37 1

Enrollment Metrics

Measure Registries
Min 242.0
1st Qu 465.0
Median 2273.5
Mean 746194.8
3rd Qu 10902.5
Max 5940299.0

Registry Model

observational_model Study_Count
Cohort 5
Case-Only 1
Family-Based 1
Other 1

Time Perspective

time_perspective Study_Count
Prospective 5
Cross-Sectional 2
Other 1

Follow-up

target_duration Study_Count
5 Years 2
1 Day 1
10 Years 1
12 Months 1
17 Years 1
36 Months 1
6 Years 1

Overview of Studies

Interventional Trials

#If less then 500 trials

nct_id brief_title link overall_status source primary_completion_date
NCT04271735 Pilot Study to Evaluate the Effect of Nicotinamide Riboside on Immune Activation in Psoriasis https://ClinicalTrials.gov/show/NCT04271735 Recruiting National Institutes of Health Clinical Center (CC) 2022-01-31
NCT03382756 A Clinical Trial to Assess the Effects of Food on the Bioavailability of CKD-337 https://ClinicalTrials.gov/show/NCT03382756 Completed Chong Kun Dang Pharmaceutical 2017-11-02
NCT03370848 Effects of Psyllium on Niacin Tolerability https://ClinicalTrials.gov/show/NCT03370848 Completed VA Greater Los Angeles Healthcare System 2011-07-31
NCT03367663 The Effect of Prednisone on Atherogenesis as Studied in the Macrophage Foam Cell Formation Model System. https://ClinicalTrials.gov/show/NCT03367663 Completed Rambam Health Care Campus 2018-07-09
NCT03418974 Safety and Efficacy of Statins for Chinese Patients With Dyslipidemia https://ClinicalTrials.gov/show/NCT03418974 Active, not recruiting Fudan University 2021-12-31
NCT03338426 A Study to Evaluate the Efficacy and Safety of Combination Treatment of Fimasartan/Atorvastatin in Patients With Essential Hypertension and Dyslipidemia https://ClinicalTrials.gov/show/NCT03338426 Completed Boryung Pharmaceutical Co., Ltd 2019-04-22
NCT03307031 The Influence of Pilates Exercises Training Volume on Metabolic Outcomes in Dyslipidemic Women. https://ClinicalTrials.gov/show/NCT03307031 Completed Federal University of Rio Grande do Sul 2017-07-28
NCT03295448 Fatty Acid Biomarkers of Carbohydrate Intake https://ClinicalTrials.gov/show/NCT03295448 Completed Uppsala University 2018-06-01
NCT03294044 The Effectiveness of Smart Health Management Program for Patients With Chronic Illness https://ClinicalTrials.gov/show/NCT03294044 Completed Seoul National University Hospital 2018-03-26
NCT03291548 Quinoa Biscuit & CVD Risk Trial https://ClinicalTrials.gov/show/NCT03291548 Completed University of Ulster 2017-06-19
NCT03284918 Lipid Lowering Effect of a Cereal Based Snack Bar With Added Plant Stanol Ester https://ClinicalTrials.gov/show/NCT03284918 Completed Raisio Group 2016-03-31
NCT03267329 Duowell® vs. Telmisartan Monotherapy in Mild Dyslipidemia Patients With Hypertension https://ClinicalTrials.gov/show/NCT03267329 Recruiting Yuhan Corporation 2020-08-31
NCT03254446 Safety and Efficacy Study of TRC150094 to Improve the CV Risk in Subjects With Diabetes, Dyslipidemia and Hypertension https://ClinicalTrials.gov/show/NCT03254446 Recruiting Torrent Pharmaceuticals Limited 2020-04-30
NCT03251690 Switching TDF/FTC/EFV to TDF/FTC/RPV VS Continuing TDF/FTC/EFV in HIV Patients With Complete Virological Suppression https://ClinicalTrials.gov/show/NCT03251690 Completed Mahidol University 2018-04-30
NCT03247140 The PK Characteristics of the Co-administration of Rosuvastatin and Telmisartan/Amlodipine and JLP-1401 in Healthy Male Volunteers Volunteers https://ClinicalTrials.gov/show/NCT03247140 Completed Jeil Pharmaceutical Co., Ltd. 2017-08-07
NCT03241121 Study of Eating Patterns With a Smartphone App and the Effects of Time Restricted Feeding in the Metabolic Syndrome https://ClinicalTrials.gov/show/NCT03241121 Active, not recruiting University of Lausanne Hospitals 2020-03-31
NCT03235362 A Clinical Trial to Investigate the Pharmacokinetic Drug Interaction Between YHR1705 and YHR1706 https://ClinicalTrials.gov/show/NCT03235362 Completed Yuhan Corporation 2017-09-19
NCT03221816 Effect of Polyvitaminics (Pyridoxine Hydrochloride, Folic Acid and Cyanocobalamin) in the Concentration of Homocysteine and Lipid Profile in Postmenopausal Women: a Randomized Controlled, Double-blind Clinical Trial https://ClinicalTrials.gov/show/NCT03221816 Completed Casa de Saúde santa Marcelina 2010-01-31
NCT03210649 Study to Investigate the Safety/Tolerability and Pharmacokinetics/Pharmacodynamics of CKD-519 https://ClinicalTrials.gov/show/NCT03210649 Completed Chong Kun Dang Pharmaceutical 2017-04-24
NCT03210532 Evaluate the Efficacy and Safety of Combination Treatment With DW1501-R1+DW1501-R2 Versus DW1501-R1 or DW1501-R2+DW1501-R3 in Patients With Hypertension and Dyslipidemia https://ClinicalTrials.gov/show/NCT03210532 Completed Daewon Pharmaceutical Co., Ltd. 2017-09-30
NCT03207945 Effect of PCSK9 Inhibition on Cardiovascular Risk in Treated HIV Infection (EPIC-HIV Study) https://ClinicalTrials.gov/show/NCT03207945 Recruiting University of California, San Francisco 2021-11-30
NCT03203915 Metabolic Response to Chardonnay Grape Marc Powder https://ClinicalTrials.gov/show/NCT03203915 Completed USDA, Western Human Nutrition Research Center 2019-06-28
NCT03175835 Study to Evaluate the Drug Interaction Between CKD-519 and Rosuvastatin in Healthy Male Subjects https://ClinicalTrials.gov/show/NCT03175835 Completed Chong Kun Dang Pharmaceutical 2017-06-19
NCT03173495 Effects of Exercise on Fructose-induced Postprandial Lipemia https://ClinicalTrials.gov/show/NCT03173495 Completed Federal University of Rio Grande do Sul 2016-12-15
NCT03170752 Implementing and Testing a Cardiovascular Assessment Screening Program (CASP) https://ClinicalTrials.gov/show/NCT03170752 Completed Memorial University of Newfoundland 2018-09-29
NCT03167996 Chronic Cardiovascular Risk Outpatient Management in South Asians Using Digital Health Technology https://ClinicalTrials.gov/show/NCT03167996 Completed Stanford University 2018-03-01
NCT03133975 Vitamin D Supplementation for Treatment of Dyslipidemia https://ClinicalTrials.gov/show/NCT03133975 Recruiting Mansoura University 2018-12-31
NCT03109834 Effect of Weight Management Programs on Cardiometabolic Risk Profile in Overweight Women https://ClinicalTrials.gov/show/NCT03109834 Completed Bonn Education Association for Dietetics r.A., Cologne, Germany 2007-03-28
NCT03104543 Communicating Health Information and Improving Coordination With Primary Care https://ClinicalTrials.gov/show/NCT03104543 Enrolling by invitation Fred Hutchinson Cancer Research Center 2022-03-01
NCT03088254 Study to Evaluate the Efficacy and Safety of Telmisartan/Amlodipine/Rosuvastatin https://ClinicalTrials.gov/show/NCT03088254 Completed Jeil Pharmaceutical Co., Ltd. 2017-07-31
NCT03080935 Fourier Open-label Extension Study in Subjects With Clinically Evident Cardiovascular Disease in Selected European Countries https://ClinicalTrials.gov/show/NCT03080935 Active, not recruiting Amgen 2022-12-04
NCT03071692 Pemafibrate to Reduce Cardiovascular OutcoMes by Reducing Triglycerides IN patiENts With diabeTes (PROMINENT) https://ClinicalTrials.gov/show/NCT03071692 Active, not recruiting Kowa Research Institute, Inc. 2022-04-30
NCT03068078 A Reduced-carbohydrate Diet High in Monounsaturated Fats in Type 2 Diabetes https://ClinicalTrials.gov/show/NCT03068078 Recruiting Odense University Hospital 2019-12-31
NCT03027336 Efficacy and Tolerability of the Nutraceutical Formulation Coleosoma in Dyslipidemic Subjects https://ClinicalTrials.gov/show/NCT03027336 Completed Azienda Ospedaliero-Universitaria di Parma 2016-08-31
NCT03026933 Evaluate the Efficacy and Safety of KI1107 in Patients Whose TG Level is Not Adequately Controlled With Rosuvastatin Calcium Monotherapy While LDL-C is Properly Controlled https://ClinicalTrials.gov/show/NCT03026933 Completed Kuhnil Pharmaceutical Co., Ltd. 2016-03-31
NCT03025451 Retrospective Evaluation of Athens Complete Health Improvement Program (CHIP) Database https://ClinicalTrials.gov/show/NCT03025451 Completed Ohio University 2015-12-31
NCT03021889 Nutritional Therapy Improves Dyslipidemia in HIV Infected Teenagers With Antiretroviral Treatment https://ClinicalTrials.gov/show/NCT03021889 Completed Hospital de Clinicas de Porto Alegre 2015-11-30
NCT03019263 Berberine, Chlorogenic Acid and Tocotrienols in Menopause-associated Dyslipidemia https://ClinicalTrials.gov/show/NCT03019263 Completed IRCCS Policlinico S. Matteo 2018-01-12
NCT02991534 Cardiovascular Risk Screening and Risk Reduction in Women Vets https://ClinicalTrials.gov/show/NCT02991534 Recruiting VA Office of Research and Development 2020-08-31
NCT02990260 Effect of Saccharomyces Cerevisiae in LDL Cholesterol https://ClinicalTrials.gov/show/NCT02990260 Completed Lesaffre International 2017-11-30
NCT02982408 Impact of Overfeeding and Following Exercise Training in Individuals With and Without Increased Risk of Type 2 Diabetes https://ClinicalTrials.gov/show/NCT02982408 Completed Rigshospitalet, Denmark 2019-03-31
NCT02977884 Complete Health Improvement Program (CHIP) Risk Reduction/Claims Evaluation Project https://ClinicalTrials.gov/show/NCT02977884 Recruiting Ohio University 2020-11-30
NCT02977065 To Assess the Safety, Efficacy and Tolerability of CKD-519, Administered With HMG-CoA Reductase Inhibitors https://ClinicalTrials.gov/show/NCT02977065 Completed Chong Kun Dang Pharmaceutical 2017-12-30
NCT02959762 Vitamin K to Slow Progression of Dyslipidemia and Diabetes Risk (Vita-K ‘n’ Kids Study II) https://ClinicalTrials.gov/show/NCT02959762 Active, not recruiting Augusta University 2020-12-01
NCT02956590 Dyslipidemia of Obesity Intervention in Teens https://ClinicalTrials.gov/show/NCT02956590 Recruiting HealthCore-NERI 2024-04-30
NCT02944383 A 12-Week Study to Assess the Efficacy Safety and Tolerability of Gemcabene in Subjects With Severe Hypertriglyceridemia https://ClinicalTrials.gov/show/NCT02944383 Completed NeuroBo Pharmaceuticals Inc. 2018-01-11
NCT02938091 Dietary Modulation of Hepatic Lipase (LIPC) -514 C/T Variant Associations With Lipids and Glucose https://ClinicalTrials.gov/show/NCT02938091 Completed Tufts University 2012-07-31
NCT02933658 Study of Multiple Oral Dosing to Evaluate the Safety and the Pharmacokinetic Drug-drug Interaction of Telmisartan/Amlodipine and Rosuvastatin in Healthy Male Volunteers https://ClinicalTrials.gov/show/NCT02933658 Completed Daewon Pharmaceutical Co., Ltd. 2015-11-30
NCT02900612 Effects of Two Aquatic Training Models in Physiological Parameters of Elderly Dyslipidemic Women. https://ClinicalTrials.gov/show/NCT02900612 Completed Hospital de Clinicas de Porto Alegre 2016-03-31
NCT02899455 Clinical Efficacy and Safety Evaluation of Co-administered HGP0904, HGP0608 and HGP0816 in Patients With Hypertension and Dyslipidemia https://ClinicalTrials.gov/show/NCT02899455 Completed Hanmi Pharmaceutical Company Limited 2016-06-30
NCT02881658 The Effect of 3-Week Consumption of Soya Beverage Enriched With Plant Sterols on Serum LDL-C https://ClinicalTrials.gov/show/NCT02881658 Completed The University of Hong Kong 2017-02-01
NCT02867813 Further Cardiovascular Outcomes Research With PCSK9 Inhibition in Subjects With Elevated Risk Open-label Extension https://ClinicalTrials.gov/show/NCT02867813 Active, not recruiting Amgen 2021-09-29
NCT02835651 Saturated Fatty Acids and HDL Metabolism https://ClinicalTrials.gov/show/NCT02835651 Completed Maastricht University Medical Center 2017-07-01
NCT02837367 Use of Nutrigenomic Models for the Personalized Treatment With Medical Foods in Obese People https://ClinicalTrials.gov/show/NCT02837367 Recruiting University of Medicine and Pharmacy “Victor Babes” Timisoara 2019-09-30
NCT02835287 Diabetes Complication Control in Community Clinics (D4C) Trial https://ClinicalTrials.gov/show/NCT02835287 Active, not recruiting Tulane University 2021-06-30
NCT02827903 Metformin/Rosuvastatin Combination Therapy With in Patients With Type 2 Diabetes and Dyslipidemia https://ClinicalTrials.gov/show/NCT02827903 Completed Jeil Pharmaceutical Co., Ltd. 2017-11-21
NCT02781675 The Mediterranean Full-Fat Dairy Study https://ClinicalTrials.gov/show/NCT02781675 Completed UCSF Benioff Children’s Hospital Oakland 2018-06-30
NCT02772900 Aging, Nitrate, Endothelial Function and Muscle Oxygenation https://ClinicalTrials.gov/show/NCT02772900 Completed Universidade Federal do Rio de Janeiro 2015-11-30
NCT02753504 Study to Investigate the Safety/Tolerability and Pharmacokinetics/Pharmacodynamics of CKD-519 https://ClinicalTrials.gov/show/NCT02753504 Completed Chong Kun Dang Pharmaceutical 2016-07-31
NCT02739984 Evaluation of Evolocumab (AMG 145) Efficacy in Diabetic Adults With Hypercholesterolemia/Mixed Dyslipidemia https://ClinicalTrials.gov/show/NCT02739984 Completed Amgen 2017-08-03
NCT02730559 Motivational Interviewing With Dyslipidemic Adolescents Together With a Parent Versus With Adolescents Alone: A Mixed Methods Clinical Trial https://ClinicalTrials.gov/show/NCT02730559 Completed The Hospital for Sick Children 2014-06-30
NCT02729025 Effects of Proprotein Convertase Subtilisin/Kexin Type 9 (PCSK9) Inhibition on Arterial Wall Inflammation in Patients With Elevated Lipoprotein(a) (Lp(a)) https://ClinicalTrials.gov/show/NCT02729025 Completed Amgen 2018-04-05
NCT02727036 Effect of Pumpkin Seed Oil or Pumpkin Seeds on Blood Pressure and Menopausal Symptoms in Postmenopausal Women https://ClinicalTrials.gov/show/NCT02727036 Completed Texas Woman’s University 2017-06-16
NCT02726555 The Efficacy and Safety of Combined Therapy With Red Yeast Rice and Low-dose Statin:Comparing With Standardized Statin https://ClinicalTrials.gov/show/NCT02726555 Recruiting Wenzhou Medical University 2019-05-31
NCT02726100 SMARTHealth Diabetes in China Using Lay Family Health Promoters https://ClinicalTrials.gov/show/NCT02726100 Active, not recruiting The George Institute for Global Health, China 2019-12-31
NCT02714569 A Study to Evaluate LY3202328 in Overweight Healthy Participants and Dyslipidemia https://ClinicalTrials.gov/show/NCT02714569 Completed Eli Lilly and Company 2017-02-28
NCT02676830 Evaluation of Absorption, Metabolism, and Excretion and Estimation of the Absolute Bioavailability of K-312 https://ClinicalTrials.gov/show/NCT02676830 Completed Kowa Research Institute, Inc. 2015-02-28
NCT02662569 Safety and Efficacy of Evolocumab in Combination With Statin Therapy in Adults With Diabetes and Hyperlipidemia or Mixed Dyslipidemia https://ClinicalTrials.gov/show/NCT02662569 Completed Amgen 2017-12-06
NCT02651753 A Clinical Trial to Compare Safety and Pharmacokinetic Characteristics of CKD-337 https://ClinicalTrials.gov/show/NCT02651753 Completed Chong Kun Dang Pharmaceutical 2016-03-31
NCT02644109 Effect On Serum Cholesterol Of Dairy Products With Addition Of Esterified Phytosterols https://ClinicalTrials.gov/show/NCT02644109 Completed University of Chile 2016-03-31
NCT02642159 Efficacy and Safety of Alirocumab Versus Usual Care on Top of Maximally Tolerated Statin Therapy in Patients With Type 2 Diabetes and Mixed Dyslipidemia (ODYSSEY DM-Dyslipidemia) https://ClinicalTrials.gov/show/NCT02642159 Completed Sanofi 2017-03-22
NCT02637115 Evaluation of the Effects Associated With the Administration of Akkermansia Muciniphila on Parameters of Metabolic Syndrome https://ClinicalTrials.gov/show/NCT02637115 Completed Université Catholique de Louvain 2018-02-20
NCT02628990 Lipid-lowering Effect of Plant Stanol Ester Yoghurt Drinks https://ClinicalTrials.gov/show/NCT02628990 Completed Raisio Group 2005-08-31
NCT02609243 Diabetes Nutrition Algorithm - Prediabetes https://ClinicalTrials.gov/show/NCT02609243 Recruiting German Institute of Human Nutrition 2020-12-31
NCT02586129 Clinical Trial of YH14755 in Subjects With Dyslipidemia and Type II Diabetes https://ClinicalTrials.gov/show/NCT02586129 Completed Yuhan Corporation 2017-07-07
NCT02557412 Effect of Nasal CPAP on Lipid Profile in Patients With Dyslipidaemia and Sleep Apnea https://ClinicalTrials.gov/show/NCT02557412 Recruiting Hospital Universitario La Paz 2019-12-31
NCT02541201 The Effect of a Plant Sterols-Enriched Low-Fat Milk on Lipid Profile in Healthy Southern Chinese (COME-PASS) https://ClinicalTrials.gov/show/NCT02541201 Completed The University of Hong Kong 2015-09-30
NCT02529709 The Effect of Meal Composition on Blood Lipids https://ClinicalTrials.gov/show/NCT02529709 Completed Texas Christian University 2016-04-30
NCT02523391 Bioequivalence Study of Capsule and Tablet Formulations of TA-8995 https://ClinicalTrials.gov/show/NCT02523391 Completed Xention Ltd 2015-11-30
NCT02484482 Study to Investigate the Effect of Food on the Pharmacokinetics/Pharmacodynamics and Safety of CKD-519(CKD-519 FDI) https://ClinicalTrials.gov/show/NCT02484482 Completed Chong Kun Dang Pharmaceutical 2015-08-31
NCT02480816 Cardiometabolic Response to a Sodium-bicarbonated Mineral Water https://ClinicalTrials.gov/show/NCT02480816 Completed National Research Council, Spain 2015-11-01
NCT02459496 Diabetes Nutrition Algorithms in Patients With Overt Diabetes Mellitus https://ClinicalTrials.gov/show/NCT02459496 Recruiting German Institute of Human Nutrition 2020-12-31
NCT02458287 Efficacy, Safety, Tolerability And Actual Use Study Of Bococizumab And An Autoinjector (Pre-Filled Pen) In Subjects With Hyperlipidemia Or Dyslipidemia https://ClinicalTrials.gov/show/NCT02458287 Completed Pfizer 2016-02-29
NCT02442700 Effects of Pitavastatin on Lipid Profiles in HIV-infected Patients With Dyslipidemia and Receiving Atazanavir/Ritonavir https://ClinicalTrials.gov/show/NCT02442700 Completed Ramathibodi Hospital 2015-01-31
NCT02433288 Rosuvastatin Adherence App Study in China https://ClinicalTrials.gov/show/NCT02433288 Completed AstraZeneca 2016-10-28
NCT02418715 Effects of Water-Based Exercise on Lipid Profile and Lipoprotein Lipase of Dyslipidemic Premenopausal Women https://ClinicalTrials.gov/show/NCT02418715 Completed Hospital de Clinicas de Porto Alegre 2011-06-30
NCT02407548 The Effects of Dietary Supplement of Coenzyme Q10(CoQ10) on Dyslipidemia https://ClinicalTrials.gov/show/NCT02407548 Completed Sun Yat-sen University 2017-04-30
NCT02380911 Statins at the Primary Care Level https://ClinicalTrials.gov/show/NCT02380911 Completed Institute for Clinical Effectiveness and Health Policy 2017-04-30
NCT02364258 Pharmacokinetics of Rosuvastatin and Atorvastatin in Pediatric Dyslipidemia Patients https://ClinicalTrials.gov/show/NCT02364258 Completed Children’s Mercy Hospital Kansas City 2017-12-27
NCT02358109 The Flamenco (Fitness League Against MENopause COsts) Project https://ClinicalTrials.gov/show/NCT02358109 Completed Universidad de Granada 2015-11-30
NCT02343497 Lipid-lowering Effects of an Astaxanthin Supplement in Volunteers With Mild Dyslipidaemia https://ClinicalTrials.gov/show/NCT02343497 Completed Ajinomoto Foods Europe SAS 2015-09-30
NCT02331043 Serum Cholesterol Reduction Efficacy of Biscuit With Plant Stanol Ester https://ClinicalTrials.gov/show/NCT02331043 Completed Raisio Group 2013-08-31
NCT02316808 Cholesterol-lowering Effects of Plant Stanol Ester https://ClinicalTrials.gov/show/NCT02316808 Completed Raisio Group 2011-12-31
NCT02312492 Development of a Novel Method to Study in Vivo Fatty Acid Metabolism Using Stable Isotope Labeled Fatty Acids in Humans https://ClinicalTrials.gov/show/NCT02312492 Completed Tufts University 2016-06-30
NCT02304926 Effects of Simvastatin and Ezetimibe on Cardiovascular Risk Markers in Patients With Dyslipidemia https://ClinicalTrials.gov/show/NCT02304926 Completed Fundación para el Fomento de la Investigación Sanitaria y Biomédica de la Comunitat Valenciana 2011-12-31
NCT02302612 The CREATE Wellness Study https://ClinicalTrials.gov/show/NCT02302612 Completed Kaiser Permanente 2018-09-30
NCT02281253 Effects of a Bakery Product Enriched With Fibre and L-carnitine on Insulin Resistance in Patients With Metabolic Syndrome https://ClinicalTrials.gov/show/NCT02281253 Completed Fundación para el Fomento de la Investigación Sanitaria y Biomédica de la Comunitat Valenciana 2012-07-31
NCT02275156 Estimation Study to Assess the Effect of Severe Renal Impairment and End-stage Renal Disease Hemodialysis on the Pharmacokinetics of Evolocumab https://ClinicalTrials.gov/show/NCT02275156 Completed Amgen 2014-12-19
NCT02262143 Phase III Study of Rosuvastatin and Fenofibrate Versus Rosuvastatin in Mixed Dyslipidemia https://ClinicalTrials.gov/show/NCT02262143 Completed IlDong Pharmaceutical Co Ltd 2016-10-31
NCT02247635 Effect of a Treatment of Lifestyle Changes on the Prevalence of Metabolic Syndrome and Body Weight in Mexican Women https://ClinicalTrials.gov/show/NCT02247635 Completed Mexican National Institute of Public Health 2009-05-31
NCT02241759 Study of the Electrocardiographic Effects of TA-8995 https://ClinicalTrials.gov/show/NCT02241759 Completed Xention Ltd 2014-11-30
NCT02236533 Healthy Effects of an Innovative Probiotic Pasta https://ClinicalTrials.gov/show/NCT02236533 Completed University of Parma 2014-09-30
NCT02230345 Effects of a Probiotics on the Health of Normal Young Males https://ClinicalTrials.gov/show/NCT02230345 Completed Centre Hospitalier Universitaire Vaudois 2014-12-31
NCT02223793 Vascular Lifestyle-Intervention and Screening in Pharmacy https://ClinicalTrials.gov/show/NCT02223793 Active, not recruiting University of Oslo 2015-12-31
NCT02221973 Effect of a Low Fat Milk Product on Lipids Profile in Dyslipidemia Subjects https://ClinicalTrials.gov/show/NCT02221973 Completed Nestlé 2014-10-31
NCT02221297 Lipid-lowering Effect of a Plant Stanol Ester Supplement Product https://ClinicalTrials.gov/show/NCT02221297 Completed Raisio Group 2014-11-30
NCT02207634 Evaluating PCSK9 Binding antiBody Influence oN coGnitive HeAlth in High cardiovascUlar Risk Subjects https://ClinicalTrials.gov/show/NCT02207634 Completed Amgen 2016-11-11
NCT02189837 Effects on Lipoprotein Metabolism From PCSK9 Inhibition Utilizing a Monoclonal Antibody https://ClinicalTrials.gov/show/NCT02189837 Completed Amgen 2015-02-13
NCT02180035 Treatment With Nutritional Eating Plan and Dietary Fibers in Adult Patients With HIV/AIDS https://ClinicalTrials.gov/show/NCT02180035 Completed Conselho Nacional de Desenvolvimento Científico e Tecnológico 2011-07-31
NCT02166814 A Randomized, Double-blind, Multicenter, Phase III Study to Evaluate the Efficacy and Safety of Combination of Fimasartan/Rosuvastatin in Comparison to Each Component Administered Alone in Patients With Essential Hypertension and Dyslipidemia https://ClinicalTrials.gov/show/NCT02166814 Completed Boryung Pharmaceutical Co., Ltd 2015-09-30
NCT02166593 Clinical Trial to Evaluate the Efficacy and Safety of Pravafenix Cap to Verify the Superiority Than Atorvastatin https://ClinicalTrials.gov/show/NCT02166593 Completed Yooyoung Pharmaceutical Co., Ltd. 2018-01-31
NCT02156544 Study to Investigate the Safety/Tolerability and Pharmacokinetics/Pharmacodynamics of CKD-519 https://ClinicalTrials.gov/show/NCT02156544 Completed Chong Kun Dang Pharmaceutical 2014-10-31
NCT02153879 Characterization of High Density Lipoprotein (HDL) in Type 2 Diabetes (T2D) After Fenofibrate or Niacin Treatment https://ClinicalTrials.gov/show/NCT02153879 Completed Institut Investigacio Sanitaria Pere Virgili 2011-12-31
NCT02145936 Effect of Dietary Fatty Acids on Cardiovascular Disease Risk Indicators and Inflammation https://ClinicalTrials.gov/show/NCT02145936 Completed Tufts University 2017-06-30
NCT02143011 Stress and Sugar Synergy https://ClinicalTrials.gov/show/NCT02143011 Completed University of California, Davis 2016-12-31
NCT02126358 Gemigliptin-Rosuvastatin Fix-dose Combination Phase 3(BALANCE) https://ClinicalTrials.gov/show/NCT02126358 Completed LG Life Sciences 2016-03-31
NCT02103049 The Impact of Ezetimibe on Biochemical Markers of Cardiovascular Risk in Kidney Transplant Patients https://ClinicalTrials.gov/show/NCT02103049 Completed University Medical Centre Ljubljana 2015-11-30
NCT02100514 Randomized Clinical Trial of Bococizumab (PF-04950615; RN316) in Subjects With Primary Hyperlipidemia or Mixed Dyslipidemia At Risk Of Cardiovascular Events https://ClinicalTrials.gov/show/NCT02100514 Completed Pfizer 2016-07-15
NCT02094768 Soda and Milk Study https://ClinicalTrials.gov/show/NCT02094768 Completed UCSF Benioff Children’s Hospital Oakland 2016-09-30
NCT02073084 A Thorough Corrected QT Interval Trial https://ClinicalTrials.gov/show/NCT02073084 Completed Kowa Research Institute, Inc. 2014-03-31
NCT02066207 CKD-337 Drug Interaction Study https://ClinicalTrials.gov/show/NCT02066207 Completed Chong Kun Dang Pharmaceutical 2014-04-07
NCT01301066 A 12-Week Study Comparing Pitavastatin 4 mg vs. Pravastatin 40 mg in HIV-Infected Subjects https://ClinicalTrials.gov/show/NCT01301066 Completed Kowa Research Institute, Inc. 2013-03-31
NCT01286311 Tailored Communication to Reduce Cardiovascular Risk https://ClinicalTrials.gov/show/NCT01286311 Completed Northwestern University 2013-01-31
NCT01285544 The Efficacy and Tolerability of Two Formulations of Atorvastatin In Korean Adult With Hypercholesterolemia https://ClinicalTrials.gov/show/NCT01285544 Completed Seoul National University Hospital 2009-07-31
NCT01282190 Effectiveness of Motivational Interview in Patients With Dyslipidemia https://ClinicalTrials.gov/show/NCT01282190 Completed Hospital Universitario Reina Sofia de Cordoba 2015-03-31
NCT01278693 Effect of Oral L-carnitine Supplement on Lipid Profile, Anemia, and Quality of Life of Patients https://ClinicalTrials.gov/show/NCT01278693 Completed Isfahan University of Medical Sciences 2010-09-30
NCT01271751 Pilot Study With GFT505 (80mg) in Atherogenic Dyslipidaemic Patients With Abdominal Obesity https://ClinicalTrials.gov/show/NCT01271751 Completed Genfit 2009-09-30
NCT02057302 A Study on Postmarketing Xuezhikang Capsule for Treating Dyslipidemia https://ClinicalTrials.gov/show/NCT02057302 Completed China Academy of Chinese Medical Sciences 2012-12-31
NCT02048410 Efficacy of a New Symbiotic Formulation in Children With Familial Hypercholesterolemia https://ClinicalTrials.gov/show/NCT02048410 Completed Federico II University 2012-09-30
NCT02041104 Impact of Consumption of Beta-glucans on the Intestinal Microbiota and Glucose and Lipid Metabolism https://ClinicalTrials.gov/show/NCT02041104 Completed Mlinotest Zivilska Industrija d.d. 2018-04-30
NCT02037685 Improving Adherence to Statins Among Minority Populations https://ClinicalTrials.gov/show/NCT02037685 Completed University of Miami 2015-12-31
NCT02030041 Effect of Vitamin D Supplementation on Exercise Adaptations in Patients on Statin Therapy https://ClinicalTrials.gov/show/NCT02030041 Completed Postgraduate Institute of Medical Education and Research 2015-12-31
NCT02029625 Compare the Pharmacokinetics of NVP-1205 and Coadministration of Rosuvastatin and Ezetimibe https://ClinicalTrials.gov/show/NCT02029625 Completed Navipharm Corporation 2014-03-31
NCT02028702 Alternative Treatments for Menopausal Women https://ClinicalTrials.gov/show/NCT02028702 Completed Aarhus University Hospital 2014-12-31
NCT02013843 Treatment of Overweight and Obese Children -Using the “Holbaek-Method” in a Municipality Based Treatment Program. https://ClinicalTrials.gov/show/NCT02013843 Completed Holbaek Sygehus 2015-03-31
NCT01990391 Brazil Nut Consumption in Microvascular Endothelial Function, Oxidative Stress and Metabolic Abnormalities https://ClinicalTrials.gov/show/NCT01990391 Completed Universidade Federal do Rio de Janeiro 2013-04-30
NCT01975961 PK Study of Telmisartan/Rosuvastatin FDC Compared to Combination of Telmisartan and Rosuvastatin https://ClinicalTrials.gov/show/NCT01975961 Completed Yuhan Corporation 2013-08-31
NCT03346187 A Clinical Trial to Compare Safety and Pharmacokinetic Characteristics of CKD-337 https://ClinicalTrials.gov/show/NCT03346187 Completed Chong Kun Dang Pharmaceutical 2017-05-31
NCT01972113 Vitamin K and Glucose Metabolism in Children at Risk for Diabetes (Vita-K ‘n’ Kids Study) https://ClinicalTrials.gov/show/NCT01972113 Recruiting Augusta University 2020-08-30
NCT01970215 TA-8995: Its Use in Patients With Mild Dyslipidaemia (TULIP) https://ClinicalTrials.gov/show/NCT01970215 Completed Xention Ltd 2014-07-31
NCT01968967 Randomized Clinical Trial of Bococizumab (PF-04950615; RN316) in Subjects With Hyperlipidemia or Mixed Dyslipidemia at Risk of Cardiovascular Events https://ClinicalTrials.gov/show/NCT01968967 Completed Pfizer 2016-07-05
NCT01968954 Randomized Clinical Trial Of Bococizumab (PF-04950615; RN316) In Subjects With Hyperlipidemia Or Mixed Dyslipidemia At Risk Of Cardiovascular Events https://ClinicalTrials.gov/show/NCT01968954 Completed Pfizer 2016-04-30
NCT01968720 Pilot Study To Assess CAT-2003 in Patients With Severe Hypertriglyceridemia https://ClinicalTrials.gov/show/NCT01968720 Completed Catabasis Pharmaceuticals 2014-04-30
NCT01967355 Prolongation of Pregnancy in Preeclampsia by Therapeutic Lipid Apheresis https://ClinicalTrials.gov/show/NCT01967355 Completed University Hospital Freiburg 2014-05-08
NCT01958775 Regulation of Intestinal and Hepatic Lipoprotein Production by Glucagon Like Peptide 2 https://ClinicalTrials.gov/show/NCT01958775 Completed University Health Network, Toronto 2014-06-30
NCT01953328 Study of Low-Density Lipoprotein Cholesterol (LDL-C) Reduction Using Evolocumab (AMG 145) in Japanese Patients With Advanced Cardiovascular Risk https://ClinicalTrials.gov/show/NCT01953328 Completed Amgen 2014-06-30
NCT01912560 Pilot Study To Assess CAT-2003 in Patients With Hyperlipidemia https://ClinicalTrials.gov/show/NCT01912560 Completed Catabasis Pharmaceuticals 2013-12-31
NCT01893515 The Efficacy and Safety of PRC-4016 in Hypertriglyceridemic Subjects https://ClinicalTrials.gov/show/NCT01893515 Completed Pronova BioPharma 2014-07-31
NCT01884714 Exploring the Molecular Basis to Healthy Obesity: The Diabetes Risk Assessment Study https://ClinicalTrials.gov/show/NCT01884714 Completed University of Guelph 2013-12-31
NCT01883401 Chronic Effects of Freeze-Dried Strawberry Beverage on Cardiovascular Risk Factors https://ClinicalTrials.gov/show/NCT01883401 Completed Oklahoma State University 2013-03-31
NCT01882517 Lipid-lowering Effect of Plant Stanol Yogurt https://ClinicalTrials.gov/show/NCT01882517 Completed Raisio Group 2012-01-31
NCT01879319 Study to Assess in Home Use of Evolocumab (AMG 145) Administration Using Either an Automated Mini-doser or a Prefilled Autoinjector/Pen https://ClinicalTrials.gov/show/NCT01879319 Completed Amgen 2013-12-31
NCT01879020 Evaluation of Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of TA-8995 After Multiple Doses in Healthy Subjects https://ClinicalTrials.gov/show/NCT01879020 Completed Mitsubishi Tanabe Pharma Corporation 2010-06-30
NCT01878474 Evaluation of Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of TA-8995 With Single, Escalating Doses in Healthy Subjects https://ClinicalTrials.gov/show/NCT01878474 Completed Mitsubishi Tanabe Pharma Corporation 2009-06-30
NCT01854918 Open-label Extension Study of Evolocumab (AMG 145) in Adults With Hyperlipidemia and Mixed Dyslipidemia https://ClinicalTrials.gov/show/NCT01854918 Completed Amgen 2018-05-31
NCT01849497 Study to Assess In-home Use of Evolocumab (AMG 145) Using a Prefilled Syringe or a Prefilled Autoinjector/Pen https://ClinicalTrials.gov/show/NCT01849497 Completed Amgen 2013-09-02
NCT01806506 Randomized Comparison of Laparoscopic Sleeve Gastrectomy and Gastric Bypass for Morbid Obesity https://ClinicalTrials.gov/show/NCT01806506 Completed Medical University of Warsaw 2012-03-31
NCT01806142 Effects of Medium-Chain Triglycerides on Chylomicron Secretion and Expression of Genes That Regulate Intestinal Lipid Metabolism in Men With Dyslipidemia Associated With the Metabolic Syndrome https://ClinicalTrials.gov/show/NCT01806142 Completed Laval University 2012-04-30
NCT01803594 Feeding Trial to Determine How Combinations of Different Dietary Bioactive Ingredients Influence High Density Lipoprotein (HDL) Metabolism https://ClinicalTrials.gov/show/NCT01803594 Active, not recruiting University of California, Davis 2027-03-13
NCT01792648 Effects of Almond Intake on Atherogenic Lipoprotein Particles https://ClinicalTrials.gov/show/NCT01792648 Completed UCSF Benioff Children’s Hospital Oakland 2016-02-29
NCT01778244 Metformin for Treatment of Antipsychotic-induced Dyslipidemia https://ClinicalTrials.gov/show/NCT01778244 Completed Central South University 2011-12-31
NCT01768481 Intima Media Thickness Regression in Dyslipidemic Teenagers https://ClinicalTrials.gov/show/NCT01768481 Completed Université de Montréal 2009-12-31
NCT01764633 Further Cardiovascular Outcomes Research With PCSK9 Inhibition in Subjects With Elevated Risk https://ClinicalTrials.gov/show/NCT01764633 Completed Amgen 2016-11-11
NCT01764295 Clinical Study for Patients With Hypertension Associated With Dyslipidemia https://ClinicalTrials.gov/show/NCT01764295 Completed Daewoong Pharmaceutical Co. LTD. 2013-05-31
NCT01760460 A Study of the Safety and Efficacy of Anacetrapib (MK-0859) When Added to Ongoing Statin Therapy in Japanese Participants With Dyslipidemia (MK-0859-051 AM1) https://ClinicalTrials.gov/show/NCT01760460 Completed Merck Sharp & Dohme Corp. 2015-03-04
NCT01729156 Effects of Metformin on Hepatic FFA Metabolism https://ClinicalTrials.gov/show/NCT01729156 Completed University of Aarhus 2017-05-05
NCT01725594 A Single and Multiple Ascending Dose Study to Assess the Safety, Pharmacokinetics and Pharmacodynamics of CAT-2003 https://ClinicalTrials.gov/show/NCT01725594 Completed Catabasis Pharmaceuticals 2013-05-31
NCT01696097 The Effects of Pork vs. Chicken/Fish in a DASH Diet on Blood Pressure Regulation in Middle Aged and Older Adults https://ClinicalTrials.gov/show/NCT01696097 Completed Purdue University 2014-02-28
NCT01695837 Live Well: A Practical and Effective Low-Intensity Dietary Counseling Intervention for Use in Primary Care Patients With Dyslipidemia https://ClinicalTrials.gov/show/NCT01695837 Completed University of Nevada, Las Vegas 2012-05-31
NCT01674712 A 12-week Study to Compare the Efficacy and Safety of Fixed Combinations of Fenofibrate/Simvastatin 145/20mg and Fenofibrate/Simvastatin 145/40mg Tablets Versus Fenofibrate or Simvastatin Monotherapies in Subjects With Abnormal Blood Levels of Fats (Lipids) and at High Risk of Cardiovascular Disease https://ClinicalTrials.gov/show/NCT01674712 Completed Abbott 2013-10-31
NCT01651065 Micro-Clinic Obesity and Metabolic Risk Prevention Program https://ClinicalTrials.gov/show/NCT01651065 Completed Microclinic International 2014-12-31
NCT01632358 Safety and Pharmacokinetis of TAP311 in Dyslipidemic Patients https://ClinicalTrials.gov/show/NCT01632358 Completed Novartis 2012-12-31
NCT01610661 Dietary Carbohydrate Type and Cardiovascular Disease (CVD) Risk Indicators https://ClinicalTrials.gov/show/NCT01610661 Completed Tufts University 2015-04-30
NCT01603758 Physiological Study of Human Cholesterol Metabolism and Excretion https://ClinicalTrials.gov/show/NCT01603758 Completed Washington University School of Medicine 2015-06-30
NCT01600690 Effects of 5-day Statin Withdrawal on Endothelial Progenitor Cells and Inflammatory Markers in Type 2 Diabetic Patients https://ClinicalTrials.gov/show/NCT01600690 Completed University of Padova 2013-08-31
NCT01581372 A Community Based Approach to Dyslipidemia Management: Pharmacist Prescribing to Achieve Cholesterol Targets https://ClinicalTrials.gov/show/NCT01581372 Completed University of Alberta 2013-01-31
NCT01562782 Change of Fructose to Fat in South Asians https://ClinicalTrials.gov/show/NCT01562782 Completed The Rogosin Institute 2013-10-10
NCT01559441 Beetroot Juice and Postprandial Vascular Activity https://ClinicalTrials.gov/show/NCT01559441 Completed Maastricht University Medical Center 2012-08-31
NCT01551173 Efficacy and Safety of Fluvastatin Sodium Extended Release Tablets 80 mg Once Daily in Chinese Patients With Primary Hypercholesterolemia or Mixed Dyslipidemia https://ClinicalTrials.gov/show/NCT01551173 Completed Novartis 2013-05-31
NCT01539616 A Clinical Trial to Evaluate the Safety and Efficacy of ZYH7 Compared to Fenofibrate in Patients With Dyslipidemia https://ClinicalTrials.gov/show/NCT01539616 Completed Cadila Healthcare Limited 2012-06-30
NCT01531062 Effect of Nigella Sativa on Lipid Profiles in Elderly https://ClinicalTrials.gov/show/NCT01531062 Completed Indonesia University 2011-12-31
NCT01516541 A Study of Dalcetrapib in Patients With Stable Coronary Heart Disease, With Coronary Heart Disease Risk Equivalents or at Elevated Risk for Cardiovascular Disease https://ClinicalTrials.gov/show/NCT01516541 Completed Hoffmann-La Roche 2012-07-31
NCT01502904 Neointimal Coverage After Implantation of Biolimus Eluting Stent With Biodegradable Polymer: Optical Coherence Tomographic Assessment According to the Treatment of Dyslipidemia and Hypertension and the Types of Implanted Drug-eluting Stents https://ClinicalTrials.gov/show/NCT01502904 Completed Yonsei University 2015-05-31
NCT01497912 Treatment Effects of Atorvastatin on Hemostasis and Skin Microcirculation in Patients With Type 1 Diabetes https://ClinicalTrials.gov/show/NCT01497912 Completed Karolinska Institutet 2009-01-31
NCT01487460 Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of TAP311 in Healthy Subjects and Dyslipidemic Patients https://ClinicalTrials.gov/show/NCT01487460 Completed Novartis 2012-06-30
NCT01483235 Reduced Cardiac Rehabilitation Program https://ClinicalTrials.gov/show/NCT01483235 Completed Simon Fraser University 2011-09-30
NCT01474161 Comparative Bioavailability - Gender Effect - Single and Multiple Ascending Dose Safety and Pharmacokinetic Study of GFT505 https://ClinicalTrials.gov/show/NCT01474161 Completed Genfit 2012-11-30
NCT01462877 A Study to Evaluate Fenofibrate Combination With Statin in Chinese Patients With Dyslipidemic https://ClinicalTrials.gov/show/NCT01462877 Completed Abbott 2014-02-28
NCT01458977 Trial To Assess The Lipid-Lowering Effect Of Adding Tenofovir/Emtricitabine Co-Formulation Vs Placebo To Hiv-1-Infected Subjects With Dyslipidemia And Sustained Viral Load Suppression Under Monotherapy With Ritonavir-Boosted Protease Inhibitors https://ClinicalTrials.gov/show/NCT01458977 Completed Fundacio Lluita Contra la SIDA 2014-02-28
NCT01451918 Regulation of Intestinal and Hepatic Lipoprotein Secretion by Resveratrol https://ClinicalTrials.gov/show/NCT01451918 Completed University Health Network, Toronto 2013-09-30
NCT01435382 A Pharmacokinetic and Pharmacodynamic Study of PF-04950615 (RN316) in Subjects With Hypercholesterolemia https://ClinicalTrials.gov/show/NCT01435382 Completed Pfizer 2012-02-29
NCT01427855 Dietary Protein Sources and Atherogenic Dyslipidemia https://ClinicalTrials.gov/show/NCT01427855 Completed UCSF Benioff Children’s Hospital Oakland 2016-11-30
NCT01423188 The Study of Quantitative Serial Trends in Lipids With ApolpoproteinA-I Stimulation https://ClinicalTrials.gov/show/NCT01423188 Completed Resverlogix Corp 2012-06-30
NCT01422421 Intensive Blood Pressure and LDL Lowering in Diabetic Patients With Coronary Artery Disease https://ClinicalTrials.gov/show/NCT01422421 Recruiting Kyoto University, Graduate School of Medicine 2022-03-31
NCT01420549 Efficacy/Safety of Rosuvastatin+Ezetimibe in High Risk Patients With Primary Hypercholesterolemia/Mixed Dyslipidemia https://ClinicalTrials.gov/show/NCT01420549 Completed Ache Laboratorios Farmaceuticos S.A. 2014-11-30
NCT01418716 TRANSforming InTerprofessional Cardiovascular Prevention in Primary Care https://ClinicalTrials.gov/show/NCT01418716 Completed Fonds de la Recherche en Santé du Québec 2013-10-31
NCT01414647 The Health Effect of Diet Rich in Nordic Berries https://ClinicalTrials.gov/show/NCT01414647 Completed University of Eastern Finland 2006-12-31
NCT01404897 Effects of High Fruit, Vegetable, and Dairy Intake on Plasma Lipids and Blood Pressure in Healthy Individuals https://ClinicalTrials.gov/show/NCT01404897 Completed UCSF Benioff Children’s Hospital Oakland 2013-12-31
NCT01402843 Efficacy, Safety of Coadministered Pitavastatin and Valsartan in Patients With Hypertension and Dyslipidemia https://ClinicalTrials.gov/show/NCT01402843 Completed JW Pharmaceutical 2012-06-30
NCT01394380 Reduction of Sweetened Beverages and Intrahepatic Fat https://ClinicalTrials.gov/show/NCT01394380 Completed University of Lausanne 2014-04-30
NCT01375075 A Study of LY2484595 in Japanese Subjects https://ClinicalTrials.gov/show/NCT01375075 Completed Eli Lilly and Company 2012-03-31
NCT01364961 Resveratrol and Serum Apo A-I https://ClinicalTrials.gov/show/NCT01364961 Completed Maastricht University Medical Center 2012-12-31
NCT01350843 The Effects of Orange Juice on Plasma Lipids https://ClinicalTrials.gov/show/NCT01350843 Completed University of Nottingham 2012-12-31
NCT01350141 A Multiple Dose Study Of PF-04950615 (RN316) In Subjects On Maximum Doses Of Statins https://ClinicalTrials.gov/show/NCT01350141 Completed Pfizer 2012-04-30
NCT01342211 A Multiple Dose Study of PF-04950615 (RN316) in Subjects on High Doses of Statins https://ClinicalTrials.gov/show/NCT01342211 Completed Pfizer 2012-02-29
NCT01333436 A Study to Evaluate Fasting/Postprandial Serum Apolipoprotein B-48 (ApoB-48) Levels in Diabetic Participants With Normal to Moderately High Low Density Lipoprotein-C (LDL-C) Levels (MK-0653A-259 AM1) https://ClinicalTrials.gov/show/NCT01333436 Completed Merck Sharp & Dohme Corp. 2012-05-12
NCT04447820 Study to Investigate the Efficacy and Pharmacokinetic Profile of K-877-ER Compared to K-877-IR https://ClinicalTrials.gov/show/NCT04447820 Recruiting Kowa Research Institute, Inc. 2020-12-29
NCT04439474 Determining the Effect of Vitamin D, Dyslipidemia and Microvascular in Patients With Type 2 Diabetes https://ClinicalTrials.gov/show/NCT04439474 Completed Baqiyatallah Medical Sciences University 2019-11-10
NCT04437459 The Reproducibility and Clinical Utility of an Abbreviated Fat Tolerance Test https://ClinicalTrials.gov/show/NCT04437459 Completed Oklahoma State University 2019-07-31
NCT03583905 Clinical Trial to Evaluate the Efficacy and Safety of CKD-333 Tablet https://ClinicalTrials.gov/show/NCT03583905 Completed Chong Kun Dang Pharmaceutical 2019-07-17
NCT04388215 Clinical Study to Evaluate the Efficacy and Safety of CKD-348(CKD-828, D326, D337) Tablet https://ClinicalTrials.gov/show/NCT04388215 Recruiting Chong Kun Dang Pharmaceutical 2021-04-30
NCT04348019 Effects of a Daily Time-Restricted Feeding Protocol on Diet Quality https://ClinicalTrials.gov/show/NCT04348019 Active, not recruiting Arizona State University 2020-04-30
NCT04319029 Assessment of Dyslipidemic Patients’ Knowledge, Quality of Life, and Adherence https://ClinicalTrials.gov/show/NCT04319029 Completed Al-Rasheed University College 2019-07-01
NCT04258865 A Clinical Trial to Compare the Pharmacokinetics and Tolerability of CKD-348 https://ClinicalTrials.gov/show/NCT04258865 Completed Chong Kun Dang Pharmaceutical 2020-04-26
NCT04233528 Evaluation of Systemic Microvascular Endothelial Function in Metabolically Healthy Obesity https://ClinicalTrials.gov/show/NCT04233528 Recruiting National Institute of Cardiology, Laranjeiras, Brazil 2022-06-30
NCT04186780 Effects of Lentinula Edodes Bars on Dyslipidemia and Oxidative Stress in Cholesterol Individuals: Randomized Study https://ClinicalTrials.gov/show/NCT04186780 Completed University of Sorocaba 2018-12-01
NCT04161001 Clinical Trail to Evaluate the Efficacy and Safety of DWJ1451 https://ClinicalTrials.gov/show/NCT04161001 Recruiting Daewoong Pharmaceutical Co. LTD. 2021-11-20
NCT04155645 To Assess the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of AZD8233 After Multiple Dose Administration in Subjects With Dyslipidemia https://ClinicalTrials.gov/show/NCT04155645 Recruiting AstraZeneca 2021-04-30
NCT04153617 Enriched Honey With Soluble Fiber and Polyphenols on Satiety and Dyslipidemia https://ClinicalTrials.gov/show/NCT04153617 Completed Instituto de Investigación Hospital Universitario La Paz 2019-04-19
NCT04148976 Effect of Dietary Intervention on LDL-C and Lipoprotein Subclasses Distribution in Patients With Hypercholesterolemia https://ClinicalTrials.gov/show/NCT04148976 Completed Instituto Nacional de Ciencias Medicas y Nutricion Salvador Zubiran 2018-12-18
NCT04128969 Causal Mechanisms in Adolescent Arterial Stiffness https://ClinicalTrials.gov/show/NCT04128969 Recruiting Baylor College of Medicine 2024-05-30
NCT04120753 Clinical Trial to Evaluate the Efficacy and Safety of OLOMAX Tab (Olmesartan 20 mg/Amlodipine 5 mg/Rosuvastatin 5 or 10 mg) in Hypertension Patients With Low-Intermediate Risk for Cardiovascular Disease https://ClinicalTrials.gov/show/NCT04120753 Recruiting Daewoong Pharmaceutical Co. LTD. 2020-02-29
NCT04114513 Dietary Fibers Effect on the Gut Microbiota Composition https://ClinicalTrials.gov/show/NCT04114513 Recruiting Atlas Biomed 2021-06-01
NCT04079530 A Clinical Pharmacology Study of K-877 Controlled Release Tablet https://ClinicalTrials.gov/show/NCT04079530 Active, not recruiting Kowa Company, Ltd. 2020-03-31
NCT04074551 A Phase 3 Study to Compare the Efficacy and Safety of Co-administered HGP0608, HGP0904 and HCP1306 Versus HCP1701 in Patients With Hypertension and Dyslipidemia https://ClinicalTrials.gov/show/NCT04074551 Recruiting Hanmi Pharmaceutical Company Limited 2020-03-31
NCT04061824 Clinical Study to Evaluate Adherence Improvement Fixed-dose Combination of Olostar Tab. in Patients With Hypertension and Dyslipidemia https://ClinicalTrials.gov/show/NCT04061824 Completed Yonsei University 2018-12-20
NCT04055168 A Study to Assess the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of AZD6615 in Healthy Subjects https://ClinicalTrials.gov/show/NCT04055168 Recruiting AstraZeneca 2021-08-06
NCT04037943 NUTS for the Prevention of Cardiovascular Disease in Chinese Adults https://ClinicalTrials.gov/show/NCT04037943 Active, not recruiting The George Institute for Global Health, China 2020-06-30
NCT04019743 Clinical Study to Investigate the Pharmacokinetic Profiles and Safety of CKD-333 in Healthy Volunteers https://ClinicalTrials.gov/show/NCT04019743 Completed Chong Kun Dang Pharmaceutical 2019-08-30
NCT04014686 12 Weeks of Resistance Band Exercise Impacts on Metabolic Syndrome Progression in Postmenopausal Women https://ClinicalTrials.gov/show/NCT04014686 Completed University of Nebraska, Omaha 2018-08-01
NCT04008693 Aging, Aged Garlic, Vascular Function and Muscle Oxygenation https://ClinicalTrials.gov/show/NCT04008693 Completed Universidade Federal do Rio de Janeiro 2020-01-30
NCT04003259 Get-a-Grip Lifestyle Management Programme https://ClinicalTrials.gov/show/NCT04003259 Completed Tampere University 2013-12-31
NCT03988101 Role of Statin in Venous Dysfunction in Patients With Venous Thromboembolism Event https://ClinicalTrials.gov/show/NCT03988101 Recruiting Yonsei University 2021-02-28
NCT03975556 Culturally-Adapted Diet for Puerto Rican Adults https://ClinicalTrials.gov/show/NCT03975556 Recruiting Harvard School of Public Health 2020-07-31
NCT03961763 Effect of n-3 Fatty Acid Supplementation in Hyperlipidemic Patients Taking Statins https://ClinicalTrials.gov/show/NCT03961763 Completed University of Chester 2017-11-01
NCT03960541 CD24Fc Administration to Decrease LDL and Inflammation in HIV Patients (CALIBER) https://ClinicalTrials.gov/show/NCT03960541 Recruiting OncoImmune, Inc. 2021-10-31
NCT03951207 Rosuvastatin/Amlodipine vs Atorvastatin/Amlodipine in Hypertension Patient With Dyslipidemia https://ClinicalTrials.gov/show/NCT03951207 Recruiting Yuhan Corporation 2020-08-30
NCT03949374 Clinical Trial to Evaluate Efficacy and Safety of ROVASRO 10mg Versus CRESTOR 10mg in Hypercholesterolemic Patients https://ClinicalTrials.gov/show/NCT03949374 Completed Yonsei University 2018-04-16
NCT03937960 Effect of Low Carbohydrate Versus Low Fat Diet in the Treatment of Dyslipidemia in Obese Children With Metabolic Syndrome https://ClinicalTrials.gov/show/NCT03937960 Recruiting University of Alabama at Birmingham 2020-06-30
NCT03932721 EXpanded Combination of Evolocumab Plus Empagliflozin on Diabetes: EXCEED-BHS3 Trial https://ClinicalTrials.gov/show/NCT03932721 Recruiting University of Campinas, Brazil 2020-06-30
NCT03920579 A Clinical Trial to Investigate the Pharmacokinetics and Safety/Tolerability of CKD-386 in Healthy Male Volunteers https://ClinicalTrials.gov/show/NCT03920579 Recruiting Chong Kun Dang Pharmaceutical 2019-05-31
NCT03906539 Effect of Virgin Coconut Oil (VCO) on Cardiometabolic Parameters in Patients With Dyslipidemia https://ClinicalTrials.gov/show/NCT03906539 Recruiting All India Institute of Medical Sciences, Bhubaneswar 2021-01-31
NCT03885661 Vascepa to Accelerate Lipoprotein Uptake and Elimination https://ClinicalTrials.gov/show/NCT03885661 Active, not recruiting University of Pennsylvania 2019-12-31
NCT03874260 Cinical Trial to Explore the Efficacy of Statin/Choline Fenofibrate Combination Therapy vs Statin Monotherapy in Patients With Inadequately Controlled TG Despite Receiving Statin Monotherapy https://ClinicalTrials.gov/show/NCT03874260 Recruiting Daewon Pharmaceutical Co., Ltd. 2020-01-31
NCT03805776 Intermittent Fasting in Dyslipidemia https://ClinicalTrials.gov/show/NCT03805776 Recruiting Aga Khan University 2019-06-01
NCT03795038 Comparison of the Plasma Lipoprotein Apheresis Systems DIAMED and MONET vs. the Whole Blood Apheresis System DALI https://ClinicalTrials.gov/show/NCT03795038 Recruiting Fresenius Medical Care Deutschland GmbH 2019-12-31
NCT03773315 Ulmus Macrocarpa Hance Extract and Lipid Profile https://ClinicalTrials.gov/show/NCT03773315 Completed Pusan National University Yangsan Hospital 2020-02-14
NCT03747224 Study of ARO-ANG3 in Healthy Volunteers and in Dyslipidemic Patients https://ClinicalTrials.gov/show/NCT03747224 Recruiting Arrowhead Pharmaceuticals 2020-05-30
NCT03742219 Peru Longitudinal Study https://ClinicalTrials.gov/show/NCT03742219 Recruiting Ohio University 2026-07-01
NCT03740074 Personal Activity Intelligence (PAI) Pilot https://ClinicalTrials.gov/show/NCT03740074 Recruiting Ohio University 2019-06-30
NCT03739034 Evaluation of a Lifestyle Medicine Practice https://ClinicalTrials.gov/show/NCT03739034 Recruiting Ohio University 2027-06-30
NCT03728621 Lifestyle Interventions and Metabolic Profile in Obese Children https://ClinicalTrials.gov/show/NCT03728621 Completed University of Milan 2017-06-30
NCT03726866 A Study to Investigate Drug-Drug Interaction Between D326, D337 and CKD-828 in Healthy Subjects https://ClinicalTrials.gov/show/NCT03726866 Recruiting Chong Kun Dang Pharmaceutical 2019-01-15
NCT03718286 Effects of Acute, Rapid Lowering of LDL Cholesterol With Alirocumab in Patients With STEMI Undergoing Primary PCI https://ClinicalTrials.gov/show/NCT03718286 Recruiting Population Health Research Institute 2020-07-31
NCT03707899 The PK Characteristics of the Co-administration of Rosuvastatin and Telmisartan/Amlodipine and JLP-1401 in Healthy Adult Volunteers Volunteers https://ClinicalTrials.gov/show/NCT03707899 Completed Jeil Pharmaceutical Co., Ltd. 2019-02-18
NCT03676309 Efficacy and Safety of Nutraceuticals in Patients With Diabetes Mellitus Type II and Dyslipidemia. https://ClinicalTrials.gov/show/NCT03676309 Completed Villa dei Gerani 2018-03-26
NCT03659149 Pharmacokinetics and Safety Profile of CKD-333 https://ClinicalTrials.gov/show/NCT03659149 Completed Chong Kun Dang Pharmaceutical 2018-10-05
NCT03619421 Zinc Supplement Before or With Food in Generally Healthy Men https://ClinicalTrials.gov/show/NCT03619421 Completed UCSF Benioff Children’s Hospital Oakland 2019-04-15
NCT03618797 A Clinical Trial to Evaluate the Efficacy and Safety of Pitavastatin/Fenofibrate in Complex-dyslipidemia https://ClinicalTrials.gov/show/NCT03618797 Completed Hanlim Pharm. Co., Ltd. 2018-01-31
NCT03615534 Extended Release Niacin and Fenofibrate for the Treatment of Atherogenic Dyslipidemia in Obese Females https://ClinicalTrials.gov/show/NCT03615534 Completed Al-Kindy College of Medicine 2015-06-30
NCT03611010 Dose-ranging Efficacy and Pharmacokinetics Study of Intravenous Atorvastatin in Hypercholesterolemic Patients https://ClinicalTrials.gov/show/NCT03611010 Completed Cumberland Pharmaceuticals 2020-02-17
NCT03609606 A Study to Investigate Drug Interaction Between D326, D337, and D013 in Healthy Male Subjects https://ClinicalTrials.gov/show/NCT03609606 Completed Chong Kun Dang Pharmaceutical 2018-09-14
NCT03607383 Red Rice Yeast in Low-density Lipoprotein (LDL) Lowering: an Efficacy Study https://ClinicalTrials.gov/show/NCT03607383 Recruiting Saint-Joseph University 2020-04-30
NCT03606824 Thyroid Hormone Replacement for Subclinical Hypothyroidism and Dyslipidemia in ASCVD (ThyroHeart-Lipid Study) https://ClinicalTrials.gov/show/NCT03606824 Recruiting China National Center for Cardiovascular Diseases 2020-02-28
NCT03577275 A Study to Evaluate the Effects of NST-4016 on QT/Corrected QT (QTc) Interval https://ClinicalTrials.gov/show/NCT03577275 Completed NorthSea Therapeutics B.V. 2018-09-15
NCT03557476 Effects of Octacosanol During Taekwondo Training https://ClinicalTrials.gov/show/NCT03557476 Completed University of Nebraska, Omaha 2018-03-01
NCT03532620 China Protection Trial of Glucose Metabolism by Pitavastatin in Patients With Prediabetes and Hypertension https://ClinicalTrials.gov/show/NCT03532620 Recruiting First Affiliated Hospital, Sun Yat-Sen University 2019-09-30
NCT03527290 Dietary Approaches for Cardiometabolic Health https://ClinicalTrials.gov/show/NCT03527290 Completed University of California, Irvine 2018-07-31
NCT03502109 Pharmacist-led Medication Review With Follow-up on Primary Care Cardiovascular Older Adult Patients. https://ClinicalTrials.gov/show/NCT03502109 Completed Pontificia Universidad Catolica de Chile 2019-06-30
NCT02125682 The HDL Particle Protection Study https://ClinicalTrials.gov/show/NCT02125682 Completed Hotel Dieu de France Hospital 2017-05-14
NCT03482180 Evaluate the Efficacy and Safety of KI1106 in Patients Whose TG Level is Not Adequately Controlled With Atorvastatin Calcium Monotherapy While LDL-C is Properly Controlled https://ClinicalTrials.gov/show/NCT03482180 Completed Kuhnil Pharmaceutical Co., Ltd. 2017-05-16
NCT04456192 Effects of an Indoor Cycling Program on Cardio-Metabolic Factors in Women With Obesity and Normal Body Weight https://ClinicalTrials.gov/show/NCT04456192 Completed Poznan University of Physical Education 2016-06-15
NCT03451214 Evaluation of Zinc Intake on Essential Fatty Acid Metabolism https://ClinicalTrials.gov/show/NCT03451214 Completed UCSF Benioff Children’s Hospital Oakland 2018-06-30
NCT03434613 A Randomized, Prospective, Open Label, Active Control, Phase IV Study to Evaluate the Effects of Statin Monotherapy or Statin / Ezetimibe Combination Therapy on Hepatic Steatosis in Patients With Hyperlipidemia and Nonalcoholic Fatty Liver Disease https://ClinicalTrials.gov/show/NCT03434613 Completed Yonsei University 2019-09-11
NCT03433755 Safety and Efficacy of Evolocumab in Addition to Optimal Stable Background Statin Therapy in Chinese Subjects With Primary Hypercholesterolemia and Mixed Dyslipidemia https://ClinicalTrials.gov/show/NCT03433755 Active, not recruiting Amgen 2021-08-23
NCT03415503 Dietary Anthocyanins Improve Lipid Metabolism in a Dose - Dependent Manner https://ClinicalTrials.gov/show/NCT03415503 Completed Sun Yat-sen University 2019-10-01
NCT01262638 A Study to Assess the Efficacy and Safety of ETC-1002 in Subjects With Elevated Blood Cholesterol and Either Normal or Elevated Triglycerides https://ClinicalTrials.gov/show/NCT01262638 Completed Esperion Therapeutics 2011-10-31
NCT01256476 Prevail-Us: A Study Of Pitavastatin 4 mg Vs. Pravastatin 40 mg In Patients With Primary Hyperlipidemia Or Mixed Dyslipidemia https://ClinicalTrials.gov/show/NCT01256476 Completed Kowa Research Institute, Inc. 2011-06-30
NCT01250990 Effect of Niacin on Transport of HDL and Relationship to Atherogenic Lipoproteins and Lipolysis https://ClinicalTrials.gov/show/NCT01250990 Completed University of Pennsylvania 2011-05-31
NCT01243151 Safety And Tolerability Of Multiple Doses Of PF-04950615 (RN316) In Subjects With Hypercholesterolemia https://ClinicalTrials.gov/show/NCT01243151 Completed Pfizer 2011-10-31
NCT01239004 Colesevelam Treatment for Impaired Fasting Glucose During Niacin Therapy https://ClinicalTrials.gov/show/NCT01239004 Completed Radiant Research 2011-08-31
NCT01218204 A Study to Investigate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Administering Multiple Oral Doses of GSK1292263 Alone and With Atorvastatin https://ClinicalTrials.gov/show/NCT01218204 Completed GlaxoSmithKline 2011-06-29
NCT01217112 GWMD1092 - GWP42003 : GWP42004 Together Plus Alone in Type II Diabetes https://ClinicalTrials.gov/show/NCT01217112 Completed GW Research Ltd 2012-05-31
NCT01216956 Metabolic Effects of an 8 Week Niaspan Treatment in Patients With Abdominal Obesity and Mixed Dyslipidemia https://ClinicalTrials.gov/show/NCT01216956 Completed Centre de Recherche en Nutrition Humaine Rhone-Alpe 2009-06-30
NCT01211847 Efficacy Study of Diazoxide Choline to Treat Hypertriglyceridemia https://ClinicalTrials.gov/show/NCT01211847 Completed Essentialis, Inc. 2011-09-30
NCT01205750 Hepatic Insulin Sensitivity and Very Low Density Lipoprotein Triglyceride (VLDL-TG) Kinetics https://ClinicalTrials.gov/show/NCT01205750 Completed University of Aarhus 2010-09-30
NCT01165853 Effects of Consuming Sugar-Sweetened Beverages With Meals for 10 Weeks https://ClinicalTrials.gov/show/NCT01165853 Completed University of California, Davis 2007-11-30
NCT01163851 Pharmacokinetic And Pharmacodynamic Study Of A Single-Dose Of PF-04950615 (RN316) In Combination With Atorvastatin https://ClinicalTrials.gov/show/NCT01163851 Completed Pfizer 2011-02-28
NCT01122667 Pharmacokinetics of Anacetrapib (MK0859) in Subjects With Impaired Renal Function (MK-0859-038) https://ClinicalTrials.gov/show/NCT01122667 Completed Merck Sharp & Dohme Corp. 2011-06-30
NCT01114490 Pharmacokinetics of Anacetrapib (MK0859) in Patients With Hepatic Insufficiency (MK-0859-039) https://ClinicalTrials.gov/show/NCT01114490 Completed Merck Sharp & Dohme Corp. 2010-07-31
NCT01113099 Improving Adherence to Prescribing Guidelines for Cholesterol Lowering in Hospitalized Diabetic Patients https://ClinicalTrials.gov/show/NCT01113099 Completed Washington University School of Medicine 2007-06-30
NCT01112423 Safety Study of BMS-823778 in Subjects With Hypercholesterolemia https://ClinicalTrials.gov/show/NCT01112423 Completed Bristol-Myers Squibb 2010-12-31
NCT01105975 A Study of LY2484595 in Patients With High LDL-C or Low HDL-C https://ClinicalTrials.gov/show/NCT01105975 Completed Eli Lilly and Company 2011-06-30
NCT01105598 A Multiple Ascending Dose Study of ETC-1002 in Subjects With Mild Dyslipidemia https://ClinicalTrials.gov/show/NCT01105598 Completed Esperion Therapeutics 2010-10-02
NCT01104519 A Study of Niaspan on Endothelium-Dependent and Endothelium-Independent Vascular Reactivity (0000-093) https://ClinicalTrials.gov/show/NCT01104519 Completed Merck Sharp & Dohme Corp. 2008-07-31
NCT01103921 The Metabolic Effects of Consuming Sugar-Sweetened Beverages for Two Weeks https://ClinicalTrials.gov/show/NCT01103921 Completed University of California, Davis 2014-01-31
NCT01071291 Effects of Niaspanâ„¢ on High-density Lipoprotein (HDL) in Healthy Male Subjects (0000-069) https://ClinicalTrials.gov/show/NCT01071291 Completed Merck Sharp & Dohme Corp. 2010-08-31
NCT01069783 Study of A3309 in Patients With Dyslipidemia https://ClinicalTrials.gov/show/NCT01069783 Completed Albireo 2010-09-30
NCT01058083 Safety Study of BMS-770767 in Subjects With Hypercholesterolemia https://ClinicalTrials.gov/show/NCT01058083 Completed Bristol-Myers Squibb 2011-03-31
NCT01029522 Dyslipidemia in Cardiovascular Disease https://ClinicalTrials.gov/show/NCT01029522 Completed Chong Kun Dang Pharmaceutical 2008-10-31
NCT01027325 Resistant Starch Insulin Sensitivity Trial https://ClinicalTrials.gov/show/NCT01027325 Completed UCSF Benioff Children’s Hospital Oakland 2011-08-31
NCT00990808 The Effect of MK0859 on Lipoprotein Metabolism in Patients With Dyslipidemia (0859-026 AM3) https://ClinicalTrials.gov/show/NCT00990808 Completed Merck Sharp & Dohme Corp. 2011-06-30
NCT00986986 Study of Niacin on Endothelial Function in HIV-infected Subjects With Low High Density Lipoprotein Cholesterol Levels https://ClinicalTrials.gov/show/NCT00986986 Completed University of Hawaii 2010-04-30
NCT00979368 Safety Study of BMS-816336 in Healthy Male Subjects https://ClinicalTrials.gov/show/NCT00979368 Completed Bristol-Myers Squibb 2010-02-28
NCT00977288 A Study of Safety and Efficacy of MK0859 (Anacetrapib) in Japanese Patients With Dyslipidemia (0859-029) https://ClinicalTrials.gov/show/NCT00977288 Completed Merck Sharp & Dohme Corp. 2010-03-31
NCT00961636 A Long-term Study of ERN/LRPT (Extended Release Niacin/Laropiprant [MK0524A]) in Patients With Dyslipidemia (0524A-102) https://ClinicalTrials.gov/show/NCT00961636 Completed Merck Sharp & Dohme Corp. 2011-01-31
NCT00944645 MK0524A Bioequivalence Study (0524A-059) https://ClinicalTrials.gov/show/NCT00944645 Completed Merck Sharp & Dohme Corp. 2007-01-31
NCT00943124 MK0524B Bioequivalence Study (0524B-070) https://ClinicalTrials.gov/show/NCT00943124 Completed Merck Sharp & Dohme Corp. 2007-08-31
NCT00935259 Lipid Biomarker Study in Men With Dyslipidemia After Simvastatin Treatment (Study MK-0000-140)(COMPLETED) https://ClinicalTrials.gov/show/NCT00935259 Completed Merck Sharp & Dohme Corp. 2009-10-31
NCT00928694 Fenofibrate Bioequivalence Study (0767-031) https://ClinicalTrials.gov/show/NCT00928694 Completed Merck Sharp & Dohme Corp. 2003-04-30
NCT00903617 Study to Test GSK256073 in Patients With Dyslipidemia https://ClinicalTrials.gov/show/NCT00903617 Completed GlaxoSmithKline 2010-02-16
NCT00895141 Effect of Saturated Fat on Large Low-density Lipoprotein (LDL) and High-density Lipoprotein (HDL) https://ClinicalTrials.gov/show/NCT00895141 Completed UCSF Benioff Children’s Hospital Oakland 2010-09-30
NCT00858637 Efficacy and Safety Study of MCI-196 Versus Simvastatin for Dyslipidaemia in Chronic Kidney Disease (CKD) Subjects on Dialysis https://ClinicalTrials.gov/show/NCT00858637 Completed Mitsubishi Tanabe Pharma Corporation 2010-03-31
NCT00854503 Metabolic and Vascular Effects of Statins in Untreated Dyslipidemic Diabetic Patients https://ClinicalTrials.gov/show/NCT00854503 Completed University of Rome Tor Vergata 2010-03-31
NCT00852267 Lipoprotein Effects of Substituting Beef Protein for Carbohydrate https://ClinicalTrials.gov/show/NCT00852267 Completed UCSF Benioff Children’s Hospital Oakland 2009-08-31
NCT00847197 A Study to Evaluate MK1903 in Patients With Dyslipidemia (MK1903-004) https://ClinicalTrials.gov/show/NCT00847197 Completed Merck Sharp & Dohme Corp. 2009-09-30
NCT00845637 Effect of Eggplant Extract on Lipid Profile During Fasting and Postprandial Period https://ClinicalTrials.gov/show/NCT00845637 Completed Hospital de Clinicas de Porto Alegre 2007-03-31
NCT04312698 Clinical Trial to Evaluate the Efficacy and Safety of CKD-386 https://ClinicalTrials.gov/show/NCT04312698 Recruiting Chong Kun Dang Pharmaceutical 2020-09-29
NCT04085874 Effectiveness of Food-Based Recommendations for Minangkabau Women of Reproductive Age With Dyslipidemia https://ClinicalTrials.gov/show/NCT04085874 Completed Politeknik Kesehatan Kemenkes Padang 2019-05-05
NCT03878290 RiSE to Prevent Cardiovascular Disease in African Americans https://ClinicalTrials.gov/show/NCT03878290 Completed Loyola University 2019-07-01
NCT03805139 Role of Ajwa Derived Polyphenols in Dyslipidaemias https://ClinicalTrials.gov/show/NCT03805139 Recruiting Aga Khan University 2019-11-07
NCT02833844 Safety, Tolerability & Efficacy on LDL-C of Evolocumab in Subjects With HIV & Hyperlipidemia/Mixed Dyslipidemia https://ClinicalTrials.gov/show/NCT02833844 Completed Amgen 2019-07-09
NCT00829348 Short Message Service (SMS) Impact on Patient Compliance Receiving Long Term Lipid Lowering Therapy With Statins https://ClinicalTrials.gov/show/NCT00829348 Completed Hillel Yaffe Medical Center 2009-07-31
NCT00861861 Comparison of Pitavastatin With Atorvastatin in Increasing High Density Lipoprotein - Cholesterol (HDL-C) and Adiponectin in Patients With Dyslipidemia and Coronary Artery Disease (CAD) https://ClinicalTrials.gov/show/NCT00861861 Completed Kumamoto University 2013-10-31
NCT03156842 Combination of Fimasartan/Amlodipine/Rosuvastatin in Patients With Essential Hypertension and Dyslipidemia https://ClinicalTrials.gov/show/NCT03156842 Completed Boryung Pharmaceutical Co., Ltd 2018-12-07
NCT00812955 Safety and Efficacy Study Comparing ABT-143 to Simvastatin in Subjects With Elevated Levels of Low Density Lipoprotein Cholesterol (“Bad Cholesterol”) and Triglycerides https://ClinicalTrials.gov/show/NCT00812955 Completed AstraZeneca 2009-06-30
NCT00808093 Repeat Dose Food Effect Study of GSK256073F in Healthy Adult Subjects https://ClinicalTrials.gov/show/NCT00808093 Completed GlaxoSmithKline 2008-08-27
NCT02767440 Families on Track: A Digital Health Behavioral Intervention for Parents Seeking Treatment for Their Child With Obesity https://ClinicalTrials.gov/show/NCT02767440 Completed Duke University 2017-06-30
NCT02623868 Study to Assess PK/PD Character, Safety/Tolerability of CKD-519 New Formulation in Healthy Male Subject. https://ClinicalTrials.gov/show/NCT02623868 Completed Chong Kun Dang Pharmaceutical 2015-12-31
NCT02408055 ADME Study in Healthy Male Subjects With TA-8995 https://ClinicalTrials.gov/show/NCT02408055 Completed Xention Ltd 2015-08-31
NCT02181244 Egg Effects on Atherogenic Dyslipidemias, Glucose Metabolism and Inflammation in Diabetic Subjects https://ClinicalTrials.gov/show/NCT02181244 Completed University of Connecticut 2014-01-31
NCT02168803 A Study of Evacetrapib in Participants With Abnormal Cholesterol https://ClinicalTrials.gov/show/NCT02168803 Completed Eli Lilly and Company 2015-12-31
NCT01984073 Effects of Niacin On Fatty Acid Trapping https://ClinicalTrials.gov/show/NCT01984073 Active, not recruiting University of Pennsylvania 2019-12-31
NCT01686451 The Effect of XueZhiKang on Fatigue:Comparing With Simvastatin https://ClinicalTrials.gov/show/NCT01686451 Completed Wenzhou Medical University 2013-09-30
NCT04270084 Metabolic Optimization Through Diet/Lifestyle Improvements For Youth https://ClinicalTrials.gov/show/NCT04270084 Recruiting Children’s National Research Institute 2020-06-30
NCT04110392 Effect of Consumption of Chaya on Lipid Concentration and Antioxidant Status of Patients With Dyslipidemia https://ClinicalTrials.gov/show/NCT04110392 Recruiting Hospital Regional de Alta Especialidad de la Península de Yucatán 2019-09-23
NCT04067297 Using Big Data to Conduct Innovative Cardiovascular Clinical Trials https://ClinicalTrials.gov/show/NCT04067297 Recruiting Institute for Clinical Evaluative Sciences 2021-03-31
NCT03696940 Clinical Trial to Evaluate the Efficacy of a Dyslipidemic Therapy in Mexican Population https://ClinicalTrials.gov/show/NCT03696940 Active, not recruiting Laboratorios Grossman, S.A. 2019-03-01
NCT02455336 Fenofibrate Treatment in SCI https://ClinicalTrials.gov/show/NCT02455336 Completed VA Office of Research and Development 2018-08-01
NCT00783549 A Study in Healthy Volunteers of Single Doses of Orally Administered Investigational Product to Investigate Safety, Tolerability, and Pharmacokinecs. https://ClinicalTrials.gov/show/NCT00783549 Completed GlaxoSmithKline 2009-03-31
NCT00770653 Efficacy of Pioglitazone/Metformin Combination Therapy in Subjects With Type 2 Diabetes Mellitus and Dyslipidemia. https://ClinicalTrials.gov/show/NCT00770653 Completed Takeda 2009-05-31
NCT00768274 Safety, Pharmacokinetic Study of RVX000222 in Healthy Subjects and Subjects With Low HDL Cholesterol https://ClinicalTrials.gov/show/NCT00768274 Completed Resverlogix Corp 2009-08-31
NCT00749788 Efficacy and Safety Study of JTT-302 in Subjects With Low HDL-C Levels https://ClinicalTrials.gov/show/NCT00749788 Completed Akros Pharma Inc. 2008-02-29
NCT00748852 Safety Study of JTT-302 in Subjects With Low HDL-C Levels https://ClinicalTrials.gov/show/NCT00748852 Completed Akros Pharma Inc. 2008-03-31
NCT00746460 The Healthy Options Feasibility Study https://ClinicalTrials.gov/show/NCT00746460 Completed McGill University 2009-04-30
NCT00708370 A Study to Evaluate the Efficacy of a Counselling and Advisory Care for Health (COACH) Program in Dyslipidemic Patients. https://ClinicalTrials.gov/show/NCT00708370 Completed Pfizer 2010-05-31
NCT00707746 Safety and Efficacy Study of ISIS 301012 (Mipomersen) Administration in High Risk Statin Intolerant Subjects https://ClinicalTrials.gov/show/NCT00707746 Completed Kastle Therapeutics, LLC 2010-08-31
NCT00700037 Change in Plaque Characteristics With Atorvastatin https://ClinicalTrials.gov/show/NCT00700037 Completed Wakayama Medical University 2012-02-29
NCT00697203 A Study to Assess the Effect of RO4607381 in Patients With Relatively Low Levels of High Density Lipoprotein-Cholesterol (HDL-C) https://ClinicalTrials.gov/show/NCT00697203 Completed Hoffmann-La Roche 2006-05-31
NCT00694239 Risk Assessment and Treat Compliance in Hypertension Education Trial https://ClinicalTrials.gov/show/NCT00694239 Completed Lawson Health Research Institute 2011-03-31
NCT00694109 An Open-label Extension Study to Assess the Long-term Safety and Efficacy of ISIS 301012 (Mipomersen) in Patients With Familial Hypercholesterolemia or Severe-Hypercholesterolemia https://ClinicalTrials.gov/show/NCT00694109 Completed Kastle Therapeutics, LLC 2014-09-30
NCT00689442 Safety and Efficacy Study of JTT-705 in Combination With Atorvastatin 20 mg in Patients With Low High-Density Lipoprotein (HDL) Levels https://ClinicalTrials.gov/show/NCT00689442 Completed Akros Pharma Inc. 2004-11-30
NCT00688558 Safety and Efficacy Study of JTT-705 in Combination With Simvastatin 40 mg in Patients With Low High-Density Lipoprotein (HDL) Levels https://ClinicalTrials.gov/show/NCT00688558 Completed Akros Pharma Inc. 2004-12-31
NCT00680017 30 Week Study of the Combination of ABT-335 and Rosuvastatin Compared to Rosuvastatin Monotherapy for Subjects With Dyslipidemia and Stage 3 Chronic Kidney Disease https://ClinicalTrials.gov/show/NCT00680017 Completed AstraZeneca 2011-04-30
NCT00673881 ABT-335 (Choline Fenofibrate) Reverse Cholesterol Transport (RCT) Study https://ClinicalTrials.gov/show/NCT00673881 Completed Radiant Research 2009-05-31
NCT00666250 Effects of Xoçai Antioxidant Supplements on Atherosclerosis Risk Factors https://ClinicalTrials.gov/show/NCT00666250 Completed University of Utah 2008-04-30
NCT00665834 Comparison of Rosuvastatin and Atorvastatin in Patients With Acute Coronary Syndrome https://ClinicalTrials.gov/show/NCT00665834 Completed Queen’s University 2007-09-30
NCT00664859 12-Month, Open-Label, Extension Study of LCP-AtorFen in Dyslipidemia https://ClinicalTrials.gov/show/NCT00664859 Completed Veloxis Pharmaceuticals 2009-02-28
NCT00659321 Efficacy of Nicotine Acid on Dyslipidaemia in Patients With Metabolic Syndrome https://ClinicalTrials.gov/show/NCT00659321 Completed GWT-TUD GmbH 2008-09-30
NCT00654628 Begin With The Right Patients With Dual-Inhibition Action Therapy Through Vytorin for Newly Diagnosed Dyslipidemia Patients (0653A-172)(COMPLETED) https://ClinicalTrials.gov/show/NCT00654628 Completed Merck Sharp & Dohme Corp. 2009-07-01
NCT00654602 48-wk Open Label Phase IIIb to Evaluate Efficacy and Safety https://ClinicalTrials.gov/show/NCT00654602 Completed AstraZeneca NA
NCT00654446 IIIb 6 Week Open Label Multicentre Rosuvastatin & Simvastatin https://ClinicalTrials.gov/show/NCT00654446 Completed AstraZeneca NA
NCT00654225 Treatment of Hypercholesterolaemia in South Asian Subjects (IRIS) https://ClinicalTrials.gov/show/NCT00654225 Completed AstraZeneca NA
NCT00653744 Rosuvastatin Versus Atorvastatin in the Treatment of Hypercholesterolaemia in African American Subjects(ARIES) https://ClinicalTrials.gov/show/NCT00653744 Completed AstraZeneca NA
NCT00651963 Open Label Study Evaluating The Use Of Combination Therapy Of Ezetimibe And Statins In Patients With Dyslipidemia In Colombia (0653-141)(COMPLETED) https://ClinicalTrials.gov/show/NCT00651963 Completed Merck Sharp & Dohme Corp. 2005-03-31
NCT00647543 Atorvastatin Study For The Treatment Of High Cholesterol In Patients From Thailand https://ClinicalTrials.gov/show/NCT00647543 Completed Pfizer NA
NCT00645775 Effect of Irvingia Gabonensis (Bush Mango)on Parameters Associated With Metabolic Syndrome https://ClinicalTrials.gov/show/NCT00645775 Completed Gateway Health Alliance 2007-03-31
NCT00645151 A Study Of The Efficacy Of Atorvastatin In Lowering Cholesterol In Latin American Patients With High Cholesterol https://ClinicalTrials.gov/show/NCT00645151 Completed Pfizer NA
NCT00644709 A Study Of Atorvastatin For The Treatment Of High Cholesterol In Patients At High Risk Of Coronary Heart Disease (CHD) https://ClinicalTrials.gov/show/NCT00644709 Completed Pfizer NA
NCT00644670 A Study Of The Efficacy Of Atorvastatin For Lowering Cholesterol In High-Risk Patients With High Cholesterol https://ClinicalTrials.gov/show/NCT00644670 Completed Pfizer NA
NCT00639158 Safety and Efficacy Study Comparing ABT-335 Coadministered With Atorvastatin and Ezetimibe to Atorvastatin Coadministered With Ezetimibe in Subjects With Multiple Abnormal Lipid (Fat) Levels in the Blood https://ClinicalTrials.gov/show/NCT00639158 Completed Abbott 2008-10-31
NCT00634673 Postprandial Fatty Acids and FABP2 in Type 2 Diabetes Mellitus (DM) https://ClinicalTrials.gov/show/NCT00634673 Completed Hospital de Clinicas de Porto Alegre 2007-10-31
NCT00630877 Evaluation of a Flushing ASsessment Tool (FAST) in Subjects Receiving Niacin Extended-release Plus Aspirin https://ClinicalTrials.gov/show/NCT00630877 Completed Abbott 2008-06-30
NCT00626392 Study to Evaluate the EFFECTS of Acetylsalicylic Acid (ASA) on Niaspan®-Induced Flushing in Subjects With Dyslipidemia https://ClinicalTrials.gov/show/NCT00626392 Completed Abbott 2008-04-30
NCT00625170 Metabolic Effects of Subchronic Dopamine D2 Receptor Blockade by Antipsychotic Drugs in Healthy Humans https://ClinicalTrials.gov/show/NCT00625170 Completed Leiden University Medical Center 2004-12-31
NCT00625014 Metabolic Effects of Subchronic Dopamine D2 Receptor Blockade by Haloperidol in Healthy Humans https://ClinicalTrials.gov/show/NCT00625014 Completed Leiden University Medical Center 2005-07-31
NCT00616772 Safety and Efficacy Study Using ABT-335 (Investigational Drug) in Combination With Atorvastatin, to Study the Effects on Thickening of the Blood Vessel Wall in Patients With Abnormal Lipid (Fat) Levels in the Blood https://ClinicalTrials.gov/show/NCT00616772 Completed AbbVie 2012-09-30
NCT00608699 A Study To See If GSK256073A Can Block Niacin-Induced Flushing In Healthy Volunteers https://ClinicalTrials.gov/show/NCT00608699 Completed GlaxoSmithKline 2008-04-30
NCT00607373 Study to Assess the Safety and Efficacy of ISIS 301012 (Mipomersen) in Homozygous Familial Hypercholesterolemia https://ClinicalTrials.gov/show/NCT00607373 Completed Kastle Therapeutics, LLC 2009-03-31
NCT00605787 TTA in Treatment of Diabetes and Dyslipidemia https://ClinicalTrials.gov/show/NCT00605787 Completed Haukeland University Hospital 2003-06-30
NCT00593047 LDL-Cholesterol Lowering Effect of KB2115 as Add on to Statin https://ClinicalTrials.gov/show/NCT00593047 Completed Karo Bio AB 2008-07-31
NCT00585143 Safety Study to Evaluate the Effects of Mild and Moderate Renal Impairment on the Pharmacokinetics of ABT-335 and Rosuvastatin When Administered Concomitantly https://ClinicalTrials.gov/show/NCT00585143 Completed AstraZeneca 2008-10-31
NCT00574808 Improved Delivery of Cardiovascular Care Through Outreach Facilitation https://ClinicalTrials.gov/show/NCT00574808 Completed Bruyere Research Institute 2013-02-28
NCT00551694 A Second Study to Determine the Effect of GSK256073A on HVTs https://ClinicalTrials.gov/show/NCT00551694 Completed GlaxoSmithKline 2007-12-31
NCT00542386 A Study of MCI-196 in Chronic Kidney Disease Subjects on Dialysis With Hyperphosphatemia and Dyslipidaemia https://ClinicalTrials.gov/show/NCT00542386 Completed Mitsubishi Tanabe Pharma Corporation 2009-11-30
NCT00540293 Lipitor Korean Atorvastatin Goal Achievement Across Risk Levels Study https://ClinicalTrials.gov/show/NCT00540293 Completed Pfizer 2008-05-31
NCT00535886 The Effects of Natural Versus Man-Made Trans Fatty Acids on Lipoprotein Profiles: A Pilot Study https://ClinicalTrials.gov/show/NCT00535886 Completed UCSF Benioff Children’s Hospital Oakland NA
NCT00526682 The Use of Irvingia Gabonensis (Bush Mango)and Cissus Quadrangularis to Reduce Weight and Blood Lipids https://ClinicalTrials.gov/show/NCT00526682 Completed Gateway Health Alliance NA
NCT00508937 Dietary Protein and Insulin Sensitivity Study https://ClinicalTrials.gov/show/NCT00508937 Completed UCSF Benioff Children’s Hospital Oakland 2009-11-30
NCT00506961 Evaluate the Efficacy and Safety of Rosuvastatin Versus Simvastatin in Type 2 Diabetic Patients With Dyslipidemia https://ClinicalTrials.gov/show/NCT00506961 Completed Taipei Veterans General Hospital, Taiwan 2007-07-31
NCT00504829 Study of Atorvastatin/Fenofibrate (LCP-AtorFen) Combination Therapy in Dyslipidemia https://ClinicalTrials.gov/show/NCT00504829 Completed Veloxis Pharmaceuticals 2008-02-29
NCT00493506 ProAlgaZyme Novel Algae Infusion: Applications in Immunodeficiency https://ClinicalTrials.gov/show/NCT00493506 Completed Health Enhancement Products, Inc. NA
NCT00491530 A Year 2, Safety Extension Study of the Combination of ABT-335 and Statin Therapy for Subjects With Mixed Dyslipidemia https://ClinicalTrials.gov/show/NCT00491530 Completed Abbott 2008-11-30
NCT00490178 Acceptability Study of a New Fixed Combination of Fenofibrate 80 mg BID and Metformin 1000 mg BID in Type 2 Diabetes and Dyslipidemia https://ClinicalTrials.gov/show/NCT00490178 Completed Solvay Pharmaceuticals NA
NCT00488449 Study Of Pharmacokinetics and Pharmacodynamics Effects Of GSK256073A On Healthy Volunteers https://ClinicalTrials.gov/show/NCT00488449 Completed GlaxoSmithKline 2007-11-30
NCT00487994 Safety and Efficacy of Lapaquistat Acetate Taken Alone and With Atorvastatin in Subjects With Primary Dyslipidemia https://ClinicalTrials.gov/show/NCT00487994 Completed Takeda 2007-05-31
NCT00486941 Lifestyle Intervention in Primary Health Care - the Björknäs Study https://ClinicalTrials.gov/show/NCT00486941 Completed Umeå University NA
NCT00481364 Atorvastatin Treatment to Attenuate the Progression of Cardiovascular Disease in Hemodialysis Patients https://ClinicalTrials.gov/show/NCT00481364 Completed Ege University 2008-12-31
NCT00479882 MK-0524B Lipid Study (MK-0524B-063) https://ClinicalTrials.gov/show/NCT00479882 Completed Merck Sharp & Dohme Corp. 2008-06-16
NCT00479388 Study of Extended Release Niacin/Laropiprant on Lipids (0524A-067) https://ClinicalTrials.gov/show/NCT00479388 Completed Merck Sharp & Dohme Corp. 2008-07-31
NCT00477594 Open Label Extension of ISIS 301012 (Mipomersen) to Treat Familial Hypercholesterolemia https://ClinicalTrials.gov/show/NCT00477594 Completed Kastle Therapeutics, LLC 2011-03-31
NCT00477204 Clinical Trial of Zocor (Simvastatin) and Vytorin (Ezetimibe/Simvastatin) in Adolescents With Type 1 Diabetes https://ClinicalTrials.gov/show/NCT00477204 Completed University of Colorado, Denver 2010-08-31
NCT00474864 Study To Evaluate The Effects Of GW856553 On Endothelial Function/Vascular Compliance In Subjects With Dyslipidaemia. https://ClinicalTrials.gov/show/NCT00474864 Completed GlaxoSmithKline 2008-04-30
NCT00465088 An Open-Label Study to Compare the Lipid Effects of Niacin ER and Simvastatin (NS) to Atorvastatin in Subjects With Hyperlipidemia or Mixed Dyslipidemia (SUPREME) https://ClinicalTrials.gov/show/NCT00465088 Completed Abbott 2008-02-29
NCT00463606 A Multicenter Study Comparing the Safety and Efficacy of ABT-335 and Rosuvastatin Calcium Combination Therapy to Monotherapy in Subjects With Dyslipidemia https://ClinicalTrials.gov/show/NCT00463606 Completed AstraZeneca 2008-02-29
NCT00462046 Efficacy and Safety of Berberine in the Treatment of Diabetes With Dyslipidemia https://ClinicalTrials.gov/show/NCT00462046 Completed Shanghai Jiao Tong University School of Medicine NA
NCT00455403 Atheroma Reduction With Chloroquine in Patients With the Metabolic Syndrome (ARCH-MS) https://ClinicalTrials.gov/show/NCT00455403 Completed Washington University School of Medicine 2009-12-31
NCT00447070 Effect of Atazanavir on Endothelial Function in HIV-Infected Patients https://ClinicalTrials.gov/show/NCT00447070 Completed Foundation for Cardiovascular Research, Zurich NA
NCT00442845 Establish The Benefits Of Using Various Starting Doses Of Atorvastatin On Achievement Of Cholesterol Targets (ACTFAST) https://ClinicalTrials.gov/show/NCT00442845 Completed Pfizer 2004-02-29
NCT00442325 Benefits Of Using Various Starting Doses Of Atorvastatin On Achievement Of Cholesterol Targets https://ClinicalTrials.gov/show/NCT00442325 Completed Pfizer NA
NCT00441480 Effect of Plant Sterols Esterified to Fish Oil Fatty Acids on Plasma Lipid Levels https://ClinicalTrials.gov/show/NCT00441480 Completed Enzymotec 2008-06-30
NCT00422006 Study of the Role of PCSK9 and FXR in the Physiopathology of the Joint Dyslipidemia Associated to the Human Immunoresistance https://ClinicalTrials.gov/show/NCT00422006 Completed Nantes University Hospital 2013-11-30
NCT00438061 Effect of Abdominal Obesity on Lipoprotein Metabolism https://ClinicalTrials.gov/show/NCT00438061 Completed The University of Western Australia NA
NCT00422266 Effect of Omega -3 Fatty Acids Supplements and Plant Sterol Enriched Food in Dyslipidemic Adults https://ClinicalTrials.gov/show/NCT00422266 Completed Centre for Chronic Disease Control, India NA
NCT00412113 A Multi-Risk Factor Strategy vs a Guideline-Based Approach in Achieving Blood Pressure and Lipid Goals in Hypertensives at Extra Risk https://ClinicalTrials.gov/show/NCT00412113 Completed Pfizer 2008-04-30
NCT00409240 Multi-Targeted Cardiac Risk Intervention in Type 2 Diabetes https://ClinicalTrials.gov/show/NCT00409240 Completed Providence VA Medical Center 2008-06-30
NCT00405197 MARIS Study; Mediterranean Approach to Reduce Insulin-Resistance Study https://ClinicalTrials.gov/show/NCT00405197 Completed Wageningen University NA
NCT00405171 Efavirenz to Nevirapine Switch and Low-Density Lipoprotein (LDL)-Dyslipidemia https://ClinicalTrials.gov/show/NCT00405171 Completed University Hospital, Caen NA
NCT00362908 Effects of Low and Moderate Fat Diets on Lipids, Inflammation and Vascular Reactivity in the Metabolic Syndrome https://ClinicalTrials.gov/show/NCT00362908 Completed University of Washington 2009-09-30
NCT00400231 The Fenofibrate and Metformin for Atherogenic Dyslipidemia (FAMA) Study https://ClinicalTrials.gov/show/NCT00400231 Completed University of Pennsylvania 2007-12-31
NCT00392717 Regulation of Lipoprotein Metabolism in Obese Men https://ClinicalTrials.gov/show/NCT00392717 Completed The University of Western Australia NA
NCT00385931 Efficacy and Safety of Valsartan and the Combination of Valsartan and Simvastatin https://ClinicalTrials.gov/show/NCT00385931 Completed Novartis 2003-04-30
NCT00385658 Efficacy of Fluvastatin and Fenofibrate in Comparison to Simvastatin and Ezetimibe in Patients With Metabolic Syndrome https://ClinicalTrials.gov/show/NCT00385658 Completed Novartis 2007-03-31
NCT00379756 A Study Evaluating Vardenafil Compared to Placebo in Subjects With Erectile Dysfunction (ED) and Dyslipidemia https://ClinicalTrials.gov/show/NCT00379756 Completed GlaxoSmithKline 2007-05-17
NCT00362323 Fenofibrate and Metformin Fixed Combination vs Metformin - FAME METFO https://ClinicalTrials.gov/show/NCT00362323 Completed Solvay Pharmaceuticals 2008-08-31
NCT00362180 Measure Liver Fat Content After ISIS 301012 (Mipomersen) Administration https://ClinicalTrials.gov/show/NCT00362180 Completed Kastle Therapeutics, LLC 2010-03-31
NCT00358033 Strategies to Maintain Cardiac Risk Control After Discharge From Cardiovascular Risk Reduction Clinic https://ClinicalTrials.gov/show/NCT00358033 Completed Providence VA Medical Center 2008-05-31
NCT00357955 Combined Behavioral and Pharmacological Intervention for Cardiovascular Risk Reduction in Diabetic Patients https://ClinicalTrials.gov/show/NCT00357955 Completed Providence VA Medical Center 2008-05-31
NCT00350038 Irbesartan, Ciprofibrate and Their Combination Onto the Endothelial Functions https://ClinicalTrials.gov/show/NCT00350038 Completed Sanofi NA
NCT00349128 Fenofibrate in Dyslipidemia and Metformin-Controlled Diabetes https://ClinicalTrials.gov/show/NCT00349128 Completed Solvay Pharmaceuticals NA
NCT00348751 CholGate - The Effect of Alerting Versus on Demand Computer Based Decision Support on Treatment of Dyslipidaemia by General Practitioners https://ClinicalTrials.gov/show/NCT00348751 Completed Erasmus Medical Center NA
NCT00346697 Omega-3 Fatty Acids for High Triglycerides in HIV-infected Patients https://ClinicalTrials.gov/show/NCT00346697 Completed Brown, Todd, M.D., Ph.D. 2010-04-30
NCT00345657 Efficacy Study of Extended-Release Niacin/Lovastatin Versus Usual Care https://ClinicalTrials.gov/show/NCT00345657 Completed In His Image NA
NCT00345410 Dose-Ranging Study Evaluating AVE1625 in Abdominally Obese Patients With Atherogenic Dyslipidemia https://ClinicalTrials.gov/show/NCT00345410 Completed Sanofi 2007-06-30
NCT00344370 Follow-On Study of Pitavastatin Versus Atorvastatin in Patients With Type II Diabetes Mellitus and Combined Dyslipidemia https://ClinicalTrials.gov/show/NCT00344370 Completed Kowa Research Europe 2008-04-30
NCT00344175 Follow-on Protocol of Pitavastatin Versus Simvastatin in Patients With Hypercholesterolemia or Dyslipidemia and Coronary Heart Disease Risk Factors https://ClinicalTrials.gov/show/NCT00344175 Completed Kowa Research Europe 2007-08-31
NCT00332761 Caduet in an Untreated Subject Population https://ClinicalTrials.gov/show/NCT00332761 Completed Pfizer NA
NCT00331487 Study to Compare Pioglitazone and Rosiglitazone in Subjects With Type 2 Diabetes Mellitus and Dyslipidemia https://ClinicalTrials.gov/show/NCT00331487 Completed Takeda 2004-03-31
NCT00330876 Study of Pitavastatin in Elderly Patients With Primary Hypercholesterolemia or Combined Dyslipidemia https://ClinicalTrials.gov/show/NCT00330876 Completed Kowa Research Europe 2007-12-31
NCT00330785 Open Label Study Assessing Effectiveness Of Amlodipine/Atorvastatin In Subjects With Hypertension and Dyslipidaemia https://ClinicalTrials.gov/show/NCT00330785 Completed Pfizer NA
NCT00327054 Effectiveness of Nigella Sativa (Kalonji) Seed in Dyslipidemia https://ClinicalTrials.gov/show/NCT00327054 Completed Aga Khan University NA
NCT00326326 Effect of CP-778,875 on HDL-C in Subjects With Abnormal Lipid Levels and Type 2 Diabetes. https://ClinicalTrials.gov/show/NCT00326326 Completed Pfizer NA
NCT00325780 Long-Term Extension Study of Pitavastatin in Patients With Primary Hypercholesterolemia or Combined Dyslipidemia https://ClinicalTrials.gov/show/NCT00325780 Completed Kowa Research Europe 2007-11-30
NCT00316095 Combination of Telmisartan and Simvastatin in the Treatment of Hypertension and Hypercholesterolemia https://ClinicalTrials.gov/show/NCT00316095 Completed Boehringer Ingelheim 2007-08-31
NCT00312923 Preliminary Study of Safety and Efficacy of Policosanol https://ClinicalTrials.gov/show/NCT00312923 Completed Rush University Medical Center 2009-07-31
NCT00309777 Study to Compare the Efficacy and Safety of Pitavastatin and Simvastatin https://ClinicalTrials.gov/show/NCT00309777 Completed Kowa Research Europe 2006-10-31
NCT00309751 Study Comparing Pitavastatin and Atorvastatin in Patients With Type II Diabetes Mellitus and Combined Dyslipidemia https://ClinicalTrials.gov/show/NCT00309751 Completed Kowa Research Europe 2007-06-30
NCT00309738 Study to Compare the Efficacy and Safety of Pitavastatin and Simvastatin https://ClinicalTrials.gov/show/NCT00309738 Completed Kowa Research Europe 2006-10-31
NCT00309712 Diabetes and Combined Lipid Therapy Regimen (DIACOR) Study https://ClinicalTrials.gov/show/NCT00309712 Completed Intermountain Health Care, Inc. NA
NCT00304993 Study of Niacin and Rosiglitazone in Dysmetabolic Dyslipidemia https://ClinicalTrials.gov/show/NCT00304993 Completed Foundation Research, Florida NA
NCT00300482 Evaluate Safety and Efficacy of ABT-335 in Combination With Rosuvastatin Calcium in Subjects With Multiple Abnormal Lipid Levels in the Blood https://ClinicalTrials.gov/show/NCT00300482 Completed Abbott 2006-12-31
NCT00300469 Evaluate Safety and Efficacy of ABT-335 in Combination With Atorvastatin in Subjects With Multiple Abnormal Lipid Levels in the Blood https://ClinicalTrials.gov/show/NCT00300469 Completed Abbott 2007-02-28
NCT00300456 Evaluate Safety and Efficacy of ABT-335 in Combination With Simvastatin in Subjects With Multiple Abnormal Lipid Levels in the Blood https://ClinicalTrials.gov/show/NCT00300456 Completed Abbott 2007-03-31
NCT00282659 The Use of Magnesium to Improve Blood Pressure, Cholesterol, and Glucose Control https://ClinicalTrials.gov/show/NCT00282659 Completed Hartford Hospital 2008-06-30
NCT00270439 Omentectomy for the Treatment of Diabetes Mellitus Type 2 https://ClinicalTrials.gov/show/NCT00270439 Completed Vanderbilt University 2007-01-31
NCT00268697 Efficacy of Lapaquistat Acetate Alone and With Ezetimibe in Subjects With Primary Dyslipidemia. https://ClinicalTrials.gov/show/NCT00268697 Completed Takeda 2007-01-31
NCT00267254 A Clinical Trial Comparing Torcetrapib/Atorvastatin To Simvastatin In Subjects With High Cholesterol. https://ClinicalTrials.gov/show/NCT00267254 Completed Pfizer NA
NCT00264394 Cardiovascular Risk Factor Management in HIV Infection https://ClinicalTrials.gov/show/NCT00264394 Completed University Hospital, Basel, Switzerland 2008-10-31
NCT00257686 Study to Compare the Efficacy and Safety of Pitavastatin and Pravastatin in Elderly Patients https://ClinicalTrials.gov/show/NCT00257686 Completed Kowa Research Europe 2006-05-31
NCT00256178 Efficacy of Lapaquistat Acetate and Simvastatin in Subjects With Primary Dyslipidemia. https://ClinicalTrials.gov/show/NCT00256178 Completed Takeda 2007-03-31
NCT00249938 Evaluation of Combination Cholesterol Treatments in Patients With High Cholesterol. https://ClinicalTrials.gov/show/NCT00249938 Completed University of Colorado, Denver NA
NCT00249249 Study to Compare the Efficacy of Pitavastatin With That of Atorvastatin in Lowering Cholesterol Levels https://ClinicalTrials.gov/show/NCT00249249 Completed Kowa Research Europe NA
NCT00245388 Efficacy and Safety of BMS-298585 Alone or in Combination With Pravastatin in Subjects With Mixed Dyslipidemia https://ClinicalTrials.gov/show/NCT00245388 Completed Bristol-Myers Squibb NA
NCT00240305 A Study to Investigate the Effect of Rosuvastatin (CRESTOR®) on High Density Lipoprotein Kinetics in Patients With the Metabolic Syndrome https://ClinicalTrials.gov/show/NCT00240305 Completed AstraZeneca NA
NCT00240266 Study of High Density Lipoprotein Cholesterol (HDL-C)-Raising Mechanism of Rosuvastatin (CRESTORâ„¢) by Quantifying the Key Steps of Reverse Cholesterol Transport (RCT) https://ClinicalTrials.gov/show/NCT00240266 Completed AstraZeneca 2004-11-30
NCT00239967 An International Study of Rimonabant in Dyslipidemia With AtheroGenic Risk In Abdominally Obese Patients https://ClinicalTrials.gov/show/NCT00239967 Completed Sanofi 2007-02-28
NCT00218998 Effective Endurance Training in Metabolic Syndrome https://ClinicalTrials.gov/show/NCT00218998 Completed Norwegian University of Science and Technology NA
NCT00217061 Effect of a Decision Aid About Statin Use in Patients With Type 2 Diabetes Mellitus https://ClinicalTrials.gov/show/NCT00217061 Completed Mayo Clinic 2005-10-31
NCT00194402 SLIM: Combined Effects of Slo-Niacin and Atorvastatin on Lipoproteins and Inflammatory Markers in Hyperlipidemia https://ClinicalTrials.gov/show/NCT00194402 Completed University of Washington 2006-01-31
NCT00192621 Seronegatives and Metabolic Abnormalities Protocol 2 (SAMA002): Study to Compare the Effect of Kaletra and Combivir® in HIV-Negative Healthy Subjects https://ClinicalTrials.gov/show/NCT00192621 Completed Kirby Institute 2006-12-31
NCT00174304 Open Label Study To Assess The Effectiveness Of Amlodipine-Atorvastatin Combination In Hypertension And Dyslipidemia. https://ClinicalTrials.gov/show/NCT00174304 Completed Pfizer NA
NCT00171327 Efficacy and Safety of Fluvastatin or Valsartan and Their Combination in Dyslipidemic Patients With Hypertension and Endothelial Dysfunction https://ClinicalTrials.gov/show/NCT00171327 Completed Novartis 2005-09-30
NCT00171288 Efficacy and Safety Study of Fluvastatin and Ezetimibe Combined Versus Fluvastatin Alone https://ClinicalTrials.gov/show/NCT00171288 Completed Novartis 2005-08-31
NCT00171262 Trial to Evaluate the Efficacy of Fluvastatin on Certain Markers https://ClinicalTrials.gov/show/NCT00171262 Completed Novartis 2007-06-30
NCT00171236 Efficacy and Safety of Fluvastatin in Children With Heterozygous Familial Hypercholesterolemia https://ClinicalTrials.gov/show/NCT00171236 Completed Novartis 2005-03-31
NCT00169559 Dyslipidemia Study Investigating The Increase In “Good Cholesterol” https://ClinicalTrials.gov/show/NCT00169559 Completed GlaxoSmithKline 2005-04-30
NCT00158899 GW501516 In Subjects Who Have Low Level Of High-Density Lipoprotein Cholesterol https://ClinicalTrials.gov/show/NCT00158899 Completed GlaxoSmithKline 2006-06-30
NCT00150384 Clinical Utility of Caduet in Achieving Blood Pressure and Lipid Endpoints in a Specific Patient Population https://ClinicalTrials.gov/show/NCT00150384 Completed Pfizer NA
NCT00143663 Effect of Lapaquistat Acetate on Blood Cholesterol Levels in Subjects With Elevated Cholesterol https://ClinicalTrials.gov/show/NCT00143663 Completed Takeda 2006-04-30
NCT00136799 Efficacy and Safety of Fluvastatin in Different Doses in Adults With Mixed Dyslipidemia or Primary Hypercholesterolemia https://ClinicalTrials.gov/show/NCT00136799 Completed Novartis 2006-04-30
NCT00125125 Fluvastatin in Adults With Dislipidemia With History of Muscle Problems https://ClinicalTrials.gov/show/NCT00125125 Completed Novartis 2005-12-31
NCT00116519 A Study in People With Abnormal Fat Levels in the Blood https://ClinicalTrials.gov/show/NCT00116519 Completed Eli Lilly and Company NA
NCT00111891 An Investigational Drug Study Evaluating a Novel Approach to Treat Dyslipidemia (0524A-032) https://ClinicalTrials.gov/show/NCT00111891 Completed Merck Sharp & Dohme Corp. 2005-08-31
NCT00109603 Effect of Tenofovir Disoproxil Fumarate on Lipid Levels in HIV Infected Adults on Stable Anti-HIV Drug Therapy https://ClinicalTrials.gov/show/NCT00109603 Completed National Institute of Allergy and Infectious Diseases (NIAID) 2007-07-31
NCT00108212 Effect of Diet on Men and Women With Genetic Alterations Associated With Abnormal Blood Tests https://ClinicalTrials.gov/show/NCT00108212 Completed VA Office of Research and Development NA
NCT00082251 Safety & Efficacy of a Combination Niacin ER/Simvastatin in Patients With Dyslipidemia: A Dose-Ranging Study - SEACOAST https://ClinicalTrials.gov/show/NCT00082251 Completed Kos Pharmaceuticals NA
NCT00080275 Evaluation of the Safety & Efficacy of a Combination of Niacin ER & Simvastatin in Patients With Dyslipidemia (OCEANS) https://ClinicalTrials.gov/show/NCT00080275 Completed Kos Pharmaceuticals NA
NCT00079638 Comparative Efficacy Evaluation of Lipids When Treated With Niaspan & Statin or Other Lipid-Modifying Therapies-COMPELL https://ClinicalTrials.gov/show/NCT00079638 Completed Kos Pharmaceuticals NA
NCT00029835 Obese Patients With Untreated Dyslipidemias https://ClinicalTrials.gov/show/NCT00029835 Completed Sanofi 2003-11-30
NCT00666172 Effects of Worksite Wellness Interventions on Vascular Function, Insulin Sensitivity and High-Density Lipoprotein in Overweight or Obese Women https://ClinicalTrials.gov/show/NCT00666172 Completed National Institutes of Health Clinical Center (CC) 2012-11-01
NCT00653965 Treatment of Hypercholesterolaemia in Hispanic Subjects (STARSHIP) https://ClinicalTrials.gov/show/NCT00653965 Completed AstraZeneca NA
NCT00330980 Effects of Statin Medications on Mental Processes, Behavior, and Serotonin Levels https://ClinicalTrials.gov/show/NCT00330980 Completed University of California, San Diego 2004-03-31
NCT00300430 Study to Evaluate the Long-Term Safety and Efficacy of ABT-335, in Combination With Three Different Statins in Subjects With Mixed Dyslipidemia. https://ClinicalTrials.gov/show/NCT00300430 Completed Abbott 2008-03-31
NCT00728910 Combined Effects of Non-statin Treatments on Apolipoprotein A-I Up-Regulation (CENTAUR): A Feasibility Study https://ClinicalTrials.gov/show/NCT00728910 Completed University of Pennsylvania 2009-08-31
NCT00348725 Acceptability of a Fixed Combination of Fenofibrate and Metformin https://ClinicalTrials.gov/show/NCT00348725 Completed Solvay Pharmaceuticals NA
NCT00455325 Chloroquine to Treat People With Metabolic Syndrome Aim2 (ARCH-MS) https://ClinicalTrials.gov/show/NCT00455325 Active, not recruiting Washington University School of Medicine 2020-12-31

Observational Studiess

#If less then 500 studies

nct_id brief_title link overall_status source primary_completion_date
NCT01221584 Centralized Pan-Russian Survey on the Undertreatment of Hypercholesterolemia https://ClinicalTrials.gov/show/NCT01221584 Completed AstraZeneca 2011-03-31
NCT03279770 Circulating Non-coding RNAs and Cardiovascular Outcomes in Patients With Dyslipidemia and Atherosclerosis https://ClinicalTrials.gov/show/NCT03279770 Recruiting National Taiwan University Hospital 2020-06-30
NCT03204799 Metagenomic Analysis of Human Gut Microbiota in Patients With Metabolic Diseases Including Diabetes https://ClinicalTrials.gov/show/NCT03204799 Recruiting Yonsei University 2019-09-30
NCT03139630 COPANA - A09 PCSK 9 Substudy: Impact of Protease Inhibitors on PCSK9 Levels in Naive HIV—Infected Patients https://ClinicalTrials.gov/show/NCT03139630 Completed Saint Antoine University Hospital 2016-09-30
NCT03110432 Prospective German Very High Cardiovascular Risk Patients Dyslipidemia Treatment Indication Registry https://ClinicalTrials.gov/show/NCT03110432 Recruiting GWT-TUD GmbH 2020-12-30
NCT02993120 Getting to an Improved Understanding of Low-Density Lipoprotein Cholesterol and Dyslipidemia Management (GOULD) a Registry of High Cardiovascular Risk Subjects in the United States https://ClinicalTrials.gov/show/NCT02993120 Active, not recruiting Amgen 2020-07-31
NCT02931292 A Decade of Sleeve Gastrectomy: Analysis of Short and Long-term Outcome of 562 Patients https://ClinicalTrials.gov/show/NCT02931292 Completed Medical Park Gaziantep Hospital 2015-06-30
NCT02716870 Meta-analyses of the Effect of Important Food Sources of Sugars on Cardiometabolic Risk Factors https://ClinicalTrials.gov/show/NCT02716870 Active, not recruiting University of Toronto 2020-12-31
NCT00001154 Lipoprotein Metabolism in Normal Volunteers and Patients With High Levels of Lipoproteins https://ClinicalTrials.gov/show/NCT00001154 Recruiting National Institutes of Health Clinical Center (CC) NA
NCT03403283 Dyslipidemia and Diabetic Retinopathy https://ClinicalTrials.gov/show/NCT03403283 Recruiting University of Alabama at Birmingham 2021-12-31
NCT02537535 Guidelines Oriented Approach to Lipid Lowering (GOAL) in Canada https://ClinicalTrials.gov/show/NCT02537535 Completed Canadian Heart Research Centre 2019-12-31
NCT02504736 Colesevelam, Lipids And Sugars, South Asian Canadian Trial https://ClinicalTrials.gov/show/NCT02504736 Completed Canadian Collaborative Research Network 2018-02-15
NCT02490553 Epidemiological Study on the Relationship Between Respiratory Health and Air Pollution From Industrial Sources https://ClinicalTrials.gov/show/NCT02490553 Completed University Hospital, Lille 2013-11-30
NCT02489331 Post Marketing Surveillance of Safety and Efficacy for Cholib in Korean Patients Under the “New Drug Re-examination”. https://ClinicalTrials.gov/show/NCT02489331 Recruiting Abbott 2020-11-30
NCT02478853 Impact of a Regional Program Agir Sur Sa SantE https://ClinicalTrials.gov/show/NCT02478853 Active, not recruiting Université de Sherbrooke 2017-12-31
NCT02392416 Atorvastatin Study in Cardiovascular Disease Risk https://ClinicalTrials.gov/show/NCT02392416 Completed Elpen Pharmaceutical Co. Inc. 2016-02-29
NCT02382159 A Observational Study to Evaluate Lipid-lowering Drug Its Effect on Parameters in Dyslipidemia of Type 2 Diabetes. https://ClinicalTrials.gov/show/NCT02382159 Completed Yooyoung Pharmaceutical Co., Ltd. 2015-04-30
NCT02230241 CEntralized Pan-Russian Survey of tHE Undertreatment of hypercholeSterolemia II (CEPHEUS II) https://ClinicalTrials.gov/show/NCT02230241 Completed AstraZeneca 2015-11-30
NCT02205567 Bergamot and Cardio-Metabolic Risk Factors https://ClinicalTrials.gov/show/NCT02205567 Completed University of Palermo 2015-06-30
NCT02163044 The Hellenic Postprandial Lipemia Study (HPLS) https://ClinicalTrials.gov/show/NCT02163044 Completed Hellenic College of Treatment of Atherosclerosis 2019-08-31
NCT02072837 Dyslipidemia-related Risk Factors in Dialysis https://ClinicalTrials.gov/show/NCT02072837 Completed National and Kapodistrian University of Athens 2014-01-31
NCT01304641 Cardiovascular Events Based On Statin Initiation In The Elderly https://ClinicalTrials.gov/show/NCT01304641 Completed Pfizer 2011-02-28
NCT01292018 Management of Dyslipidemia in Adult Type 2 Diabetes Patients in India https://ClinicalTrials.gov/show/NCT01292018 Completed AstraZeneca NA
NCT01988454 Characterization of Dyslipidemia in Adolescent Obesity https://ClinicalTrials.gov/show/NCT01988454 Completed Health Diagnostic Laboratory, Inc. 2014-06-30
NCT01897883 Dyslipidemia Management in Chinese Post Stroke Patients https://ClinicalTrials.gov/show/NCT01897883 Completed AstraZeneca 2014-08-31
NCT01670968 HIV Reverse Cholesterol Transport Study https://ClinicalTrials.gov/show/NCT01670968 Recruiting University College Dublin 2020-05-31
NCT01630980 Meta-analyses of the Effect of Tree Nuts on Glycemic Control and Features of the Metabolic Syndrome https://ClinicalTrials.gov/show/NCT01630980 Completed University of Toronto 2014-05-31
NCT01569867 Genetic Influence on Statin Pharmacokinetics https://ClinicalTrials.gov/show/NCT01569867 Recruiting Ohio State University 2020-06-30
NCT01564550 The Effect of Type 2 Diabetes and Dietary Regulation on VLDL1-and VLDL2-triglyceride Metabolism https://ClinicalTrials.gov/show/NCT01564550 Completed University of Aarhus 2014-12-31
NCT01487057 Lipid Metabolic Status in Thyroid Carcinoma https://ClinicalTrials.gov/show/NCT01487057 Completed Prof. Dr. I. Chiricuta Institute of Oncology 2012-02-29
NCT01436253 Study of Lipid Control in Hyperlipidemic Participants (MK-0653-179) https://ClinicalTrials.gov/show/NCT01436253 Completed Merck Sharp & Dohme Corp. 2013-02-28
NCT01414192 A Study to Design a Model Cohort for Analysis of Dyslipidemia (MK-0653A-204) https://ClinicalTrials.gov/show/NCT01414192 Completed Merck Sharp & Dohme Corp. 2014-09-15
NCT01372956 Cholesterol Goal Attainment Rate and Its Associated Factors Among Dyslipidemic Patients on Lipid-lowering Drug Therapy in Korea https://ClinicalTrials.gov/show/NCT01372956 Completed AstraZeneca 2011-10-31
NCT04306939 Genomic Resources for Enhancing Available Therapies (GREAT1.0) Study https://ClinicalTrials.gov/show/NCT04306939 Recruiting University of Pittsburgh 2025-12-01
NCT04209816 Genetic Pathways Leading to Fatty Liver and Atherogenic Dyslipidemia https://ClinicalTrials.gov/show/NCT04209816 Enrolling by invitation Helsinki University Central Hospital 2024-06-30
NCT04161859 Use of Nutraceuticals in Clinical Practice https://ClinicalTrials.gov/show/NCT04161859 Recruiting University of Pavia 2019-12-31
NCT04085016 Effect of HMG-CoA Reductase Inhibitors on the Meibomian Gland Morphology in Patients With Meibomitis https://ClinicalTrials.gov/show/NCT04085016 Recruiting National Taiwan University Hospital 2019-12-31
NCT04046289 Effects of Probiotics and Calcium Supplementation on Growth, Development, and Metabolic Parameters https://ClinicalTrials.gov/show/NCT04046289 Completed Indonesia University 2019-03-03
NCT04015726 Secular Trends in the Prevalence of Cardiometabolic Risk Factors Among Teenage School Children in Urban South India https://ClinicalTrials.gov/show/NCT04015726 Recruiting India Diabetes Research Foundation & Dr. A. Ramachandran’s Diabetes Hospitals 2020-08-31
NCT04004143 Micronutrients and Health in Adult Chinese https://ClinicalTrials.gov/show/NCT04004143 Completed Shenzhen Center for Chronic Disease Control 2013-11-30
NCT03939039 From Known to New Genes in Dyslipidemia https://ClinicalTrials.gov/show/NCT03939039 Recruiting Hospices Civils de Lyon 2024-12-01
NCT03892265 A Longitudinal Cohort Study to Evaluate Cardiovascular Risk Factors and Disease in Haiti https://ClinicalTrials.gov/show/NCT03892265 Active, not recruiting Weill Medical College of Cornell University 2024-08-01
NCT03856476 The Effect of Childhood Dyslipidemia on Endothelial and Renal Function https://ClinicalTrials.gov/show/NCT03856476 Recruiting University of Ioannina 2020-04-03
NCT03804775 Comparative Analysis of Serum Lipid Profiles in Patients With and Without Gallstones https://ClinicalTrials.gov/show/NCT03804775 Completed Services Hospital, Lahore 2018-08-30
NCT03794531 Psychosocial, Environmental, and Chronic Disease Trends in Puerto Rico https://ClinicalTrials.gov/show/NCT03794531 Recruiting Harvard School of Public Health 2022-06-30
NCT03742544 Post Marketing Surveillance of Telostop TAB (Telmisartan/Rosuvastatin) for Evaluating the Safety and Efficacy https://ClinicalTrials.gov/show/NCT03742544 Enrolling by invitation IlDong Pharmaceutical Co Ltd 2020-10-30
NCT03724825 Correlation of Serum Adropin to Testosterone and Adiponectin in Obese Men https://ClinicalTrials.gov/show/NCT03724825 Completed Aswan University Hospital 2019-11-29
NCT03691246 Research on Burden of Disease for Patients With Myocardial Infarction Combining Dyslipidemia in China https://ClinicalTrials.gov/show/NCT03691246 Recruiting China Cardiovascular Association 2019-06-30
NCT03669536 Determinants of Cognitive Impairment Among Geriatrics https://ClinicalTrials.gov/show/NCT03669536 Active, not recruiting Faculty of Medicine, Tarumanagara University 2018-12-31
NCT03449784 Assessment of Compliance With European and French Guidelines for the Management of Dyslipidaemias https://ClinicalTrials.gov/show/NCT03449784 Recruiting University Hospital, Montpellier 2040-11-01
NCT01264263 Prevalence of Subclinical Atherosclerosis and Its Associated Factors in Hyperlipidemic Korean Adults With Diabetes https://ClinicalTrials.gov/show/NCT01264263 Completed AstraZeneca 2011-04-30
NCT01245738 Effect of Statins on Lipid Levels Following the First Acute Coronary Event (MK-0000-204) https://ClinicalTrials.gov/show/NCT01245738 Completed Merck Sharp & Dohme Corp. 2012-12-31
NCT01243138 Africa and Middle East Cardiovascular Epidemiological Study https://ClinicalTrials.gov/show/NCT01243138 Completed Pfizer 2012-04-30
NCT01164397 Efficiency of Rosuvastatin Versus the Fixed Combination of Ezetimibe/Simvastatin in Outpatients https://ClinicalTrials.gov/show/NCT01164397 Completed AstraZeneca NA
NCT01101763 A Study of the Kinetics of a 13C-Cholesterol Infusate in Healthy Male Subjects (0000-108)(COMPLETED) https://ClinicalTrials.gov/show/NCT01101763 Completed Merck Sharp & Dohme Corp. 2008-11-30
NCT01075594 Study of Undertreatment of Patients With Dyslipidemia in Bulgaria https://ClinicalTrials.gov/show/NCT01075594 Completed AstraZeneca 2010-08-31
NCT01068834 Additional KIF6 Risk Offers Better Adherence to Statins https://ClinicalTrials.gov/show/NCT01068834 Completed Medco Health Solutions, Inc. 2011-04-30
NCT01055977 Statin Therapy Results in the Real World Practice in the Czech Republic https://ClinicalTrials.gov/show/NCT01055977 Completed AstraZeneca 2010-06-30
NCT01047176 Observational Study to Estimate the Rates of Outcomes in Patients Undergoing Percutaneous Coronary Intervention (PCI) With Drug Eluting Stent (DES) Implantation Who Take Statins https://ClinicalTrials.gov/show/NCT01047176 Completed AstraZeneca 2011-12-31
NCT01019200 Serum Lipid Levels and Other Biomarkers of Cardiovascular Disease in Patients With Psoriasis https://ClinicalTrials.gov/show/NCT01019200 Completed George Washington University 2016-03-31
NCT00931320 Investigation Into the RAtio of LDL-CHolestEroL to HDL-Cholesterol Improvement After Statin Treatment in Korean Patients https://ClinicalTrials.gov/show/NCT00931320 Completed AstraZeneca NA
NCT00911482 Production of Free Fatty Acids From Blood Triglycerides https://ClinicalTrials.gov/show/NCT00911482 Completed Mayo Clinic 2012-01-31
NCT00879125 Effect of Gastric Bypass on Patients With Type 2 Diabetes and/or Dyslipidemia https://ClinicalTrials.gov/show/NCT00879125 Completed Vanderbilt University 2007-11-30
NCT00858221 Association of Genes to Resistance to Weight Loss in Obese Patients https://ClinicalTrials.gov/show/NCT00858221 Completed Interleukin Genetics, Inc. 2009-04-30
NCT02808715 Identification and Metabolic Characterization of a Cohort of Human Subjects With Mutations in PRDM-16 https://ClinicalTrials.gov/show/NCT02808715 Completed National Heart Centre Singapore 2016-01-31
NCT03429517 Levels of Triglycerides and HDL-C in ACS Patients https://ClinicalTrials.gov/show/NCT03429517 Recruiting Assiut University 2019-06-01
NCT03329729 PLATOREL® STUDY IN CARDIOVASCULAR RISΚ ASSESMENT https://ClinicalTrials.gov/show/NCT03329729 Completed Elpen Pharmaceutical Co. Inc. 2019-01-30
NCT04094194 Meta-analysis of the Nordic Dietary Pattern on Cardiometabolic Risk and Cardiovascular Outcomes https://ClinicalTrials.gov/show/NCT04094194 Active, not recruiting University of Toronto 2019-12-01
NCT00726856 Retrospective Survey Evaluating the Effectiveness and Safety of Dual Inhibition Lipid-lowering in the Treatment of Dyslipidemia (Study P05171)(COMPLETED) https://ClinicalTrials.gov/show/NCT00726856 Completed Merck Sharp & Dohme Corp. 2007-07-31
NCT00701402 National Survey on Dyslipidemic Patients https://ClinicalTrials.gov/show/NCT00701402 Completed AstraZeneca NA
NCT00684151 Survey of Lipid Goal Attainment and Mortality in Patients With High Cardiovascular Risk in Thailand https://ClinicalTrials.gov/show/NCT00684151 Completed AstraZeneca NA
NCT00673660 Observational Study On Compliance Of Statin Treatment Of Patients With High Blood Cholesterol Levels https://ClinicalTrials.gov/show/NCT00673660 Completed Pfizer 2009-10-31
NCT00613613 Fenofibrate and Pharmacogenetic Impact in Dyslipidemia https://ClinicalTrials.gov/show/NCT00613613 Completed University of Minnesota 2013-10-31
NCT00557778 Education and Awareness Program Targeting the Assessment of Adherence of the Treatment of Dyslipidemia https://ClinicalTrials.gov/show/NCT00557778 Completed AstraZeneca 2010-09-30
NCT00526708 Crestor RUSH (The Efficacy of RosUvaStatin for Korean Dyslipidemia Patients With Hypertension ) https://ClinicalTrials.gov/show/NCT00526708 Completed AstraZeneca 2007-11-30
NCT00526552 Crestor RAPID (The Efficacy of RosuvAstatin for Korean Dyslipidemia PatIents With Diabetes) https://ClinicalTrials.gov/show/NCT00526552 Completed AstraZeneca 2007-08-31
NCT00487591 An Evaluation of Simvastatin Plus Omacor Compared to Simvastatin Plus Placebo in Subjects With Mixed Dyslipidemia https://ClinicalTrials.gov/show/NCT00487591 Completed Provident Clinical Research 2007-08-31
NCT00419484 Effect of Pioglitazone on Cardiovascular Outcome on Higashi-Saitama Trial in Patients With Type 2 Diabetes https://ClinicalTrials.gov/show/NCT00419484 Completed Dokkyo Medical University NA
NCT00408057 Guidelines Based Undertaking for Improvement in Dyslipidemia Related Events (GUIDE ) https://ClinicalTrials.gov/show/NCT00408057 Completed Canadian Heart Research Centre 2007-11-30
NCT00388180 An Exploratory Study To Look At The Effect Of Two Investigational Drugs On Body Fat And Inflammation https://ClinicalTrials.gov/show/NCT00388180 Completed GlaxoSmithKline NA
NCT00299884 Atorvastatin Versus Ezetimibe and Fenofibrate as a Lipid-lowering Strategy https://ClinicalTrials.gov/show/NCT00299884 Completed Queen’s University 2006-07-31
NCT00169871 Hs-CRP as Clinical Marker of Inflammatory Atherogenic Dyslipidemia https://ClinicalTrials.gov/show/NCT00169871 Completed CHU de Quebec-Universite Laval NA
NCT00147797 Influence of Pravastatin on Carotid Artery Structure and Function in HIV-infected Patients Under Antiretroviral Therapy https://ClinicalTrials.gov/show/NCT00147797 Completed Saint Antoine University Hospital NA
NCT00069004 A Study of Physical and Metabolic Abnormalities in HIV Infected and Uninfected Children and Youth https://ClinicalTrials.gov/show/NCT00069004 Completed National Institute of Allergy and Infectious Diseases (NIAID) NA

Registries

#If less then 500 registries

nct_id brief_title link overall_status source primary_completion_date
NCT03191227 The Cork and Kerry Diabetes and Heart Disease Study (Phase II) Mitchelstown Cohort https://ClinicalTrials.gov/show/NCT03191227 Completed University College Cork 2011-05-31
NCT04442334 The European NAFLD Registry https://ClinicalTrials.gov/show/NCT04442334 Recruiting Newcastle University 2030-12-31
NCT03994575 North American Acute Coronary Syndrome (ACS) Reflective III Pilot https://ClinicalTrials.gov/show/NCT03994575 Enrolling by invitation Canadian Heart Research Centre 2020-11-30
NCT03903029 Efficacy of Low-dose (10 mg) Rosuvastatin in Korean 4 Statin Benefit Groups Per 2013 ACC/AHA Guideline https://ClinicalTrials.gov/show/NCT03903029 Active, not recruiting Seoul National University Hospital 2015-07-05
NCT03861533 GOAL International QuERI https://ClinicalTrials.gov/show/NCT03861533 Recruiting Canadian Heart Research Centre 2022-04-01
NCT03847753 Exploring the Comorbidity Between Mental Disorders and General Medical Conditions https://ClinicalTrials.gov/show/NCT03847753 Completed University of Aarhus 2016-12-31
NCT03799185 Dyslipidemia Prevalence, Perception, Treatment, and Awareness in the Tunisian Population https://ClinicalTrials.gov/show/NCT03799185 Completed Association Tunisienne d’Etude & de Recherche sur l’Athérosclérose 2019-08-31
NCT04220164 Observation of Blood Lipid Outcomes in Lipid Clinic https://ClinicalTrials.gov/show/NCT04220164 Recruiting Mackay Memorial Hospital 2020-12-31